Podcast appearances and mentions of Sanjay Sharma

Abhay welcomes Sanjay Sharma, founder and CEO of Marginal Media Works, for a candid and thought-provoking conversation about the power of the margins in shaping culture, creativity, and identity.Sanjay shares his journey from growing up immersed in subcultures like skateboarding, heavy metal, and hip hop, to building a media company dedicated to amplifying voices and stories that exist at the intersections—across race, gender, sexuality, and more. Together, Abhay and Sanjay explore how “the coolest shit happens in the margins,” why authenticity matters in an era of rapid commercialization, and how intersectionality and fluid identity are transforming both the business and art of storytelling.The discussion touches on reimagining classic genres through new perspectives, the evolving landscape of representation in Hollywood, and the challenges and opportunities of navigating today's shifting sociopolitical climate. Sanjay also reflects on the importance of pattern recognition, staying connected to emerging trends, and the ongoing need to redefine what it means to belong—both on screen and off.(0:00 - 3:13) Introduction(3:13) Part 1 - prioritizing margins, politics and the moving margins(20:45) Part 2 - centers of capital and power, intersections of tech and media(34:10) Part 3 - labels and identity, optimismDon't forget to subscribe, review, follow along, and share! 

In this special National Volunteers Week 2025 episode, we celebrate the impact of Indian-Australians in their communities. Vinay Kumar aids flood victims with the NSW SES, while Kittu Randhawa supports domestic violence survivors. Sumeet Chhabra reconnects seniors through his Gurudwara, and Sanjay Sharma unites people through cricket. Student Zain Khan highlights the importance of youth volunteering. Discover how these acts of service foster a more connected Australia.

Running and cardiac health go hand in hand. In today's podcast, we revisit our conversation with Dr. Sanjay Sharma, Professor of Cardiology and Head of Research at St George's University of London as we dive deep into how running enhances cardiac health and how to safeguard ourselves from any cardiac risks that might be related to the sport.With hot and humid conditions torching the country, this podcast will help you understand the effect of the environmental conditions on the heart, the tests you can undergo to assess your heart health and the symptoms to keep an eye out for which are a great indicator to pause your running and get yourself examined by your physician.About Vikas Singh:Vikas Singh, an MBA from Chicago Booth, worked at Goldman Sachs, Morgan Stanley, APGlobale, and Reliance before coming up with the idea of democratizing fitness knowledge and helping beginners get on a fitness journey. Vikas is an avid long-distance runner, building fitpage to help people learn, train, and move better.For more information on Vikas, or to leave any feedback and requests, you can reach out to him via the channels below:Instagram: @vikas_singhhLinkedIn: Vikas SinghTwitter: @vikashsingh101Subscribe To Our Newsletter For Weekly Nuggets of Knowledge!

This week on The Mr. Beacon Podcast, Sanjay Sharma, CEO of Roambee, helps us to further explore the future of IoT enabled supply chain visibility. Discover how Roambee's real-time sensing solutions impact global trade, reducing disputes, optimizing logistics, and enabling autonomous supply chains. Sanjay shares insights on tackling modern supply chain complexities, leveraging printed battery powered GPS technologies, and achieving measurable ROI. A must-listen for supply chain professionals, this episode offers fresh perspectives on transparency, innovation, and creating smarter, more efficient operations. Sanjay's Top 3 Songs with Meaning:“Hall Of Fame” by The Script (ft. will.i.am): https://www.youtube.com/watch?v=v8xgecy_ivw“Eye Of The Tiger” by Survivor: https://www.youtube.com/watch?v=_qDML_BCju8“Unstoppable” by Sia: https://www.youtube.com/watch?v=jJvDnYdD8JQ Hosted on Acast. See acast.com/privacy for more information.

Dr. Sanjay Sharma is a Sociologist and a Researcher who completed his studies at the National University of Singapore. His doctoral research offers a gender critique of the militarization and transnational migration of Gurkha soldier families. In this podcast, he talks about the positives and negatives of migration, immigration, identity and much more.

This year, the Indian Australian Multicultural Sports Association (IAMSA), a non-profit organisation based in the Australian Capital Territory, was awarded Cricket Australia's Community Cricket Association of the Year Award. Furthermore, its director, Sanjay Sharma, received the Inclusion & Diversity Initiative of the Year Award. As a dedicated local cricket volunteer, Sharma has organised numerous tournaments, including the Multicultural World Cup and the Friendship Cup.

In this episode of Run with Fitpage, we have one of the best Sports Cardiologists in the world - Dr. Sanjay Sharma. Dr. Sharma talks about heart health, cardiac screening, a number of medical tests for runners and alot more with our host, Vikas Singh. Dr. Sanjay Sharma is a highly esteemed Professor of Cardiology and Head of Research at St George's University of London, where he leads a renowned clinical and academic group. With a focus on sudden cardiac death in the young and heart muscle diseases, Dr. Sharma boasts an international reputation, backed by over 250 PubMed citations. He serves as the director of the largest sports cardiology unit in the UK, providing essential care for athletes from prestigious organizations like the British Premier Soccer and Rugby League. As the medical director of the Virgin London Marathon and lead cardiologist for the 2012 London Olympics, Dr. Sharma has been recognized for his exceptional contributions to endurance event medical services worldwide. He is also actively involved with charity work, notably leading the largest cardiac screening program in the UK with Cardiac Risk in the Young (CRY), screening over 20,000 individuals annually and advocating for preventative measures against young sudden death.In addition to his clinical and research endeavors, Dr. Sharma is dedicated to education, having authored several educational books, including the widely acclaimed Rapid Review of Medicine. With a passion for teaching and a commitment to saving lives, Dr. Sanjay Sharma continues to make significant strides in the fields of cardiology and sports medicine, leaving an indelible mark on both his students and the broader medical community.About Vikas Singh:Vikas Singh, an MBA from Chicago Booth, worked at Goldman Sachs, Morgan Stanley, APGlobale, and Reliance before coming up with the idea of democratizing fitness knowledge and helping beginners get on a fitness journey. Vikas is an avid long-distance runner, building fitpage to help people learn, train, and move better.For more information on Vikas, or to leave any feedback and requests, you can reach out to him via the channels below:Instagram: @vikas_singhhLinkedIn: Vikas SinghTwitter: @vikashsingh101Subscribe To Our Newsletter For Weekly Nuggets of Knowledge!

Today we're speaking with Dr. Sanjay Sharma, an oncologist who has leveraged his medical and business expertise to become a highly successful commercial real estate investor.- Dr. Sharma explains how physicians can attain financial freedom without abandoning their medical careers. Learn why doctors make excellent real estate investors and syndicators and how to leverage your analytical skills.- Discover Dr. Sharma's “secret sauce” - the morning routines, business philosophies, and time management techniques that enable him to balance prospering medical and real estate careers.- You'll hear Dr. Sharma's personal real estate investing journey - how he got started, mistakes made, and lessons learned about syndicating and developing big projects. Gain priceless tips on partnering with the right professionals.If you're a physician interested in real estate or an investor looking to work with doctor-led syndicates, don't miss this insightful conversation. Dr. Sharma delivers proven methods to build wealth and find freedom.Connect with Dr. Sharman thru the social links below and learn more about his business:Instagram: www.instagram.com/hemeoncliveLinkedIn: https://www.linkedin.com/in/sanjay-sharma-md-218b05175/Website: https://www.titan3capital.com/Unlock 3+1 degrees of freedom (time, location, financial + health) with our 5-Point Blueprint! https://elevateequity.org/podcastgiftIf you really enjoyed this content and are looking for more, you can continue to learn more about us in several different places for free! on our website for blogs & other podcast interviews! elevateequity.org our YouTube channel! youtube.com/channel/derekclifford our book/audiobook! amazon.com/dp/ebook If you'd like to have a FREE copy of our 7 Ways Commercial Real Estate Syndications Protect and Build Wealth, simply click the link below. We are here and vested in your long-term success! elevateequity.org/7waysEbook

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Atrial shunt devices in heart failure Cardiovascular risk in master athletes Mythbusters: Monday mornings are dangerous Host: Susanna Price Guests: Carlos Aguiar, Sanjiv Shah, Sanjay Sharma Want to watch that episode? Go to: https://esc365.escardio.org/event/1143   Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Sanjay Sharma have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic. Sanjiv Shah has declared to have potential conflicts of interest to report: global PI for the Corvia REDUCE LAP-HF I & II and RESPONDER-HF trials of an atrial shunt device for HFpEF. Consultant to Alleviant, Edwards, and Shifamed, each of which has developed devices for atrial shunting. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

In this episode, join us as we sit down with Dr. Sanjay Sharma, a full-time Hematologist-Oncologist, who shares insights on dominating both the realms of real estate capital and the medical field. Dr. Sharma discusses his journey, emphasizing the strategic decision to incorporate real estate to attain passive growth while dabbling into his medical career.Delving into mindset shifts, he provides advice on overcoming the fear of risks and setting oneself up for long-term goals. Tune in for a unique perspective on thriving in diverse professional domains.Key Points From This Episode:Guest IntroductionThe reason why he chose real estate alongside his medical profession.How to change your mindset when you're scared of taking risks.Setting yourself up for long-term goals.Healthcare would be better if you could utilize all your skills, learning, and heart for each patient.You have to create time and learn how to manage it effectively to be productive.Categorizing the things you do using the Eisenhower Matrix.How to get into real estate if you want options and time freedom.Resources:Follow Dr. Sanjay SharmaExponential Capital Investments WebsiteEisenhower Matrix GuideBiggerpocketsListen to the previous episodes hereIf you're struggling with your vitality, energy, mood, focus, or sleep, this show is for you. You'll discover the keys to remove the barriers or blockades that have been holding you back.Please subscribe and review so we can up-level this show for you.Visit https://www.itsnotrocketscienceshow.com/podcast/ to learn moreFollow Ann Tsung MD, MPH onhttps://www.instagram.com/anntsungmd/https://www.facebook.com/AnnTsungMD/https://www.youtube.com/channel/UCv2Y9GGFtLLjf-rTCJWG2aQhttps://mobile.twitter.com/anntsungmd

As society faces complex change, it's no surprise that business schools are a microcosm of the broader debates within the corporate world. More schools these days are attempting to tackle the questions of whether and how businesses should help lead the way on environmental, social, and governance challenges of the day. Host Paul Laudicina welcomes Dr. Sanjay Sharma, Dean of the University of Vermont's Grossman School of Business, and Alyssa Stankiewicz, recent MBA graduate and Morningstar sustainable fund analyst, to discuss the future of business education. They explore the role of sustainability in mainstream business education, discuss how business school has changed over recent years, and look toward the future for aspiring business school graduates and new demands on leadership. Reimagining the Future: Bridging Generations is produced by the Global Business Policy Council at Kearney, a think tank that deciphers sweeping geopolitical, economic, social, and technological changes and their effects on the global business environment. Learn more at kearney.com/gbpc.    

In the world of real estate, syndication has gained popularity among investors looking to combine their resources for profitable opportunities. So, we invited Dr. Sanjay Sharma to share insights for physicians aiming to diversify their income. Tune in to catch a comprehensive approach to well-being in the real estate market.     Key takeaways to listen for: Why it's important to trust the sponsor in a syndication Reasons you might find it better to be an active investor Advantages of investing in real estate in California Practical tips for navigating the complexities of real estate markets Dr. Shanjay's outlook on the future of multifamily real estate     Resources: The Miracle Morning by Hal Elrod | Kindle and Paperback     About Dr. Sanjay Sharma Dr. Sanjay is a real estate professional and visionary investor making waves in the LA and Southeast multifamily markets. With a proven track record as an investor, capital raiser, and syndicator, he has brought remarkable returns to physician and high-net-worth executive investors, paving their path towards financial, geographical, temporal, vital, and mindset freedoms. Dr. Sanjay—a trailblazer in real estate, physician, and educator—continues to make a profound impact, empowering investors and transforming lives along the way. Prepare to be inspired by his exceptional journey and unwavering dedication to his profession.     Connect with Dr. Sanjay Website: Exponential – Capital Investments Linkedin: Sanjay Sharma MD  Instagram: @hemeonclive Tiktok: @hemeonclive     CONNECT WITH US Are you looking for the easiest way to grow your passive real estate portfolio? Visit Great Venture Capital to join our Investor Club today!     Follow Our Social Media Pages Facebook: Great Venture Capital LinkedIn: Great Venture Capital Connect on LinkedIn: Justin Dixon Email: Justin@GreatVentureCapital.com

In this episode, I  reconnect with Dr. Sanjay Sharma, a pioneering podiatrist revolutionising podiatry and foot care in India. Since appearing on the show three years ago, in 2020, Episode 103, Dr Sharma has established Foot Secure, a network of clinics providing complete podiatry services across Bangalore. Sanjay and his team treat up to 200 patients at their five locations daily, focusing on diabetes-related foot complications. Through early detection and intervention, Foot Secure has reduced below-knee and bony amputation rates to just 2.7%, a dramatic decrease from India's average of 19% across all hospitals.  Chapters: (01:12) We still do not have a podiatry program in India. (03:59) 1.4 billion people are screaming out for podiatrists. (05:37) Foot Secure provides comprehensive foot care for diabetic patients in India. (10:26) How Podiatry is funded in India.   (17:52) Technology is key in addressing podiatric ailments and diabetic foot ailments across India.  (28:17) His podcast, The Great Indian Podiatry Show, has helped reach out to other countries. If you want to contact Dr Sanjay Sharma, you can email him at sanjay@footsecure.com, or you can visit his website at www.footsecure.com If you have any questions about this episode or would like to make enquiries about becoming a guest on the podcast or a PODCAST SPONSORSHIP, please email me at tyson@podiatrylegends.com PODIATRY BUSINESS COACH  Hi, I'm Tyson Franklin, and if you're looking for a one-on-one podiatry business coach with a proven track record of helping podiatrists excel in business, look no further. I know I can help you.   If you'd like to talk, please email me at tf@tysonfranklin.com; otherwise, go directly to my online calendar to schedule a free 30-minute Zoom meeting.  UPCOMING EVENTS If you want to meet podiatrists who think differently and want to take their podiatry business to the next level, consider attending one of my upcoming EVENTS. Always guaranteed to deliver. 

EPISODE SUMMARY: Have you ever wondered how the principles of medicine can cross-apply to the real estate world? Dr. Sanjay Sharma, a seasoned real estate investor and full-time hematologist oncologist, joins us to share his fascinating journey and insights. From his intense medical training in the hustle and bustle of New York City to his fruitful medical practice in tranquil Orange County, Dr. Sharma explores the parallels between these two disparate yet interconnected worlds. Our conversation takes a deep dive into the exciting realm of real estate syndication. Even if you have a small budget or are new to this field, Dr. Sharma sheds light on how syndication can be your path to participate in the real estate market. He emphasizes the importance of having a trustworthy sponsor and a multi-disciplinary team, underscoring the critical role of trust in successful investing. But what fuels Dr. Sharma's commitment to both his medical profession and real estate investing? We wrap up our discussion exploring the evolution of his 'why', influenced by his grandfather, who fought for freedom alongside Mahatma Gandhi. His profound advice for budding real estate investors is as inspiring as it is practical: take action and learn from your mistakes. This episode is a treasure trove of inspiration and knowledge for both newcomers and seasoned investors. Tune in! DR. SANJAY'S BIO: Dr. Sanjay Sharma, a real estate professional and visionary investor making waves in the LA and Southeast multifamily market. With a proven track record as an investor, capital raiser, and syndicator, he has brought remarkable returns to physician and high net worth executive investors, paving their path towards financial, geographical, temporal, vital, and mindset freedoms. But there's more to Dr. Sharma than meets the eye. As a practicing physician specializing in hematology and oncology, he possesses a unique perspective, borne out of firsthand experience in understanding the needs of fellow doctors. Before his medical journey, Dr. Sharma honed his skills as an epidemiologist, focusing on public health and safety. After completing medical school at the prestigious Medical College of Virginia in 1999, he embarked on a remarkable path. He pursued an internal medicine program at Washington University in St. Louis, which ultimately led to a fellowship in hematology and oncology at Mount Sinai in NYC. Along the way, he found the love of his life and settled in Southern California, where they are raising their two amazing children. Driven by a passion for education, Dr. Sharma founded an oncology medical education company, sharing cutting-edge treatment opportunities with countless oncologists. Additionally, he is a sought-after national public speaker, captivating audiences with his expertise and captivating presence. Dr. Sanjay Sharma—trailblazer in real estate, physician, and educator—continues to make a profound impact, empowering investors and transforming lives along the way. Prepare to be inspired by his exceptional journey and unwavering dedication to his profession. GET IN TOUCH WITH DR.SANJAY: Linkedin: Sanjay Sharma MD Instagram: @hemeonclive Tiktok: @hemeonclive EPISODE CHAPTERS: (0:00:00) - Commitment and Investments in Real Estate Dr Sanjay Sharma discussed the dedication and rigor of becoming a medical specialist, the importance of knowing one's why, and physician moral injury and burnout. (0:12:56) - Doctor Investing in Real Estate Syndications Syndication enables investors to align money with goals, while multi-disciplinary teams and trust are essential for successful investing. (0:27:34) - Personal Growth and Evolving Why Dr. Sharma discussed the importance of a strong 'why', personal growth, and shared a personal insight. (0:33:12) - Real Estate Inspiration and Advice Dr. Sanjay Sharma shares advice on real estate, emphasizing action and learning from mistakes, inspired by his grandfather's legacy as a freedom fighter. If you want to know more about Dr. Jason Balara and the Know your Why Podcast: https://linktr.ee/jasonbalara Audio Track: Back To The Wood by Audionautix is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Artist: http://audionautix.com/  

Sanjay Sharma & Arsenio Hart discuss advantages of mentoring, why they started in multifamily, and advice on growing your platform. Join our multifamily investing community for FREE for in-depth courses and live networking with like-minded apartment investors at the Tribe of TitansLink to subscribe to YouTube channel: https://tinyurl.com/SubYouTubeDiaryPodcastApple Podcasts: https://tinyurl.com/AppleDiaryPodcast Spotify: https://tinyurl.com/SpotDiaryPodcast Google Podcasts: https://tinyurl.com/GoogleDiaryPodcast Follow us on:Facebook: https://www.facebook.com/DiaryAptInv/ Twitter: https://twitter.com/Diary_Apt_Inv Instagram: https://www.instagram.com/diary_of_an_apartment_investor This episode originally aired on August 4, 2023----Your host, Brian Briscoe, has been a general partner in 1000+ units worth over $100 million and has been lead sponsor, asset manager, capital raiser, and key principal on these properties. He has developed a multifamily education community called the Tribe of Titans that helps aspiring investors learn the game, network with other like-minded professionals, and get their apartment investing business to the next level. He is founder of Streamline Capital Group, which will continue to acquire multifamily assets well into the future. He retired as a Lieutenant Colonel in the United States Marine Corps in 2021.Connect with him on  LinkedInBrian@Steamlinecapital.com----Sanjay SharmaDr. Sanjay Sharma, a real estate professional and visionary investor making waves in the LA and Southeast multifamily market. With a proven track record as an investor, capital raiser, and syndicator, he has brought remarkable returns to physician and high net worth executive investors, paving their path towards financial, geographical, temporal, vital, and mindset freedoms. Driven by a passion for education, Dr. Sharma founded an oncology medical education company, sharing cutting-edge treatment opportunities with countless oncologists. Additionally, he is a sought-after national public speaker, captivating audiences with his expertise and captivating presence. Dr. Sanjay Sharma—trailblazer in real estate, physician, and educator—continues to make a profound impact, empowering investors and transforming lives along the way. Prepare to be inspired by his exceptional journey and unwavering dedication to his profession.Learn more about him at: https://excapinv.com/----Arsenio HartActive Duty Marine for 14 years as an Administrative Specialist. Serving in Japan married with 5 kids (2 sets of twins) currently looking to start my multi family investment career and build generational wealth. Have a single family investment property in Memphis TN and investing in a syndication as a limited partner.Learn more about him at: https://www.linkedin.com/in/arsenio-hart-09225a239/

As an investor, lawyer, creative savant, Sanjay Sharma has been the engine behind everything from the All Def Digital to the Clinton Administration, Machinima, numerous technology ventures, and now his very own Marginal Studios with projects nominated for, or winning at The Gotham Awards, the Independent Spirit Awards, GLAAD, NAACP Image Awards, and the Imagen Awards to name a few. On this installment of Sanjay schools us on building success in artificial intelligence, storytelling, wellness, serial entrepreneurship, and even how we should name the show. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this different, BONUS episode of Problematic Fave, we bring you into the world of press conferences! Dino-Ray Ramos moderated a press conference for the forthcoming comedy Joy Ride directed by Adele Lim and written by Cherry Chevapravatdumrong & Teresa Hsiao. They were joined at the official press conference by the movie's stars Ashley Park, Sherry Cola, Stephanie Hsu, Sabrina Wu as well as the "sexy boys" Chris Pang, Rohain Arora, and Alexander Hodge. This doesn't follow the regular Problematic Fave pod format as it is a press conference, obvi -- and it is a good ass time. The filmmakers and the cast have an unfiltered and also heartfelt conversation about the movie which explores self-discovery, friends and family -- and there's a lot of talk about chlamydia. Also, at one point, I think Sherry Cola says that Confucius was a top. Enjoy! === Problematic Fave is presented by DIASPORA and is created, hosted and produced by Dino-Ray Ramos. The series is also produced by Sanjay Sharma of Marginal MediaWorks and edited by Brian Aguilar. Joy Ride: @joyridemovie DIASPORA: thediasporatimes.com; @realdiaspora on Twitter, Instagram Dino-Ray Ramos: @dinoray on Twitter and Instagram Marginal MediaWorks: @mrgnlmedia on Instagram Send your "problematic faves" to thisisdiaspora@gmail.com and we'll share them on the pod with our guests! --- Support this podcast: https://podcasters.spotify.com/pod/show/problematicfavepod/support

There are a lot of problematic films and TV series in Hollywood, but what about the industry itself? In this week's episode Dino-Ray Ramos chats Maureen Ryan, journalist, critic and author of the book "Burn It Down: Power, Complicity, and a Call for Change in Hollywood" which unpacks the toxicity of Hollywood. If you thought there were problematic people and systems in place in the film and TV industry, than this book will prove you right and then some. Even though she unpacks a lot of the bad in Hollywood, she also gives hope with roads to making the industry less problematic -- it may take a while, but we gotta start somewhere. Nonetheless, we really get into the bad and the worse of it all and talk about our own experiences when it comes to working in an industry that we love, but clearly has a lot of problems that we hope to fix. === Problematic Fave is presented by DIASPORA and is created, hosted and produced by Dino-Ray Ramos. The series is also produced by Sanjay Sharma of Marginal MediaWorks and edited by Brian Aguilar. Maureen Ryan Buy "Burn It Down Power, Complicity, and a Call for Change in Hollywood" moryan.com @moryan66 on Instagram @moryan on Twitter DIASPORA: thediasporatimes.com; @realdiaspora on Twitter, Instagram Dino-Ray Ramos: @dinoray on Twitter and Instagram Marginal MediaWorks: @mrgnlmedia on Instagram Send your "problematic faves" to thisisdiaspora@gmail.com and we'll share them on the pod with our guests! --- Support this podcast: https://podcasters.spotify.com/pod/show/problematicfavepod/support

On this episode of the IoT For All Podcast, Sanjay Sharma, CEO of Roambee, joins Ryan Chacon to discuss supply chain visibility with IoT and AI. They talk about the current supply chain landscape, how to improve supply chain visibility, supply chain standardization, ease of implementing supply chain visibility, stakeholder collaboration, AI in the supply chain, and how to be successful with supply chain visibility. Sanjay Sharma is a strategic thought leader with two decades of entrepreneurial experience building technology startups from the ground up. As CEO of Roambee, he is responsible for leading the company's vision, driving its worldwide business growth, and increasing the company's value. Sanjay has successfully co-founded and led two successful Silicon Valley B2B technology venture-backed startups with successful exits - KeyTone Technologies, which was acquired by Global Asset Tracking Ltd and Plexus Technologies, which became an ICICI Ventures portfolio company. He has also been a part of the engineering teams at EMC, Schlumberger, and NASA. Roambee offers better supply chain visibility on demand, for on-time, in-full, in-condition delivery of shipments and assets anywhere in the world. 300+ enterprises are improving customer experience, service levels, product quality, cash cycles, business efficiencies, sustainability, and automated logistics with Roambee's real-time insights & foresights. More than 50 of them are among the top 100 global companies in the Pharma, Food, Electronics, Chemicals, Automotive, Packaging & Containers, and Logistics sectors. Roambee's innovative AI-powered platform, and end-to-end monitoring solutions, deliver curated and highly accurate supply chain signals built on item-level, firsthand IoT sensor data and non-sensor inputs.  Discover more about supply chain and IoT at https://www.iotforall.com More about Roambee: https://www.roambee.com Connect with Sanjay: https://www.linkedin.com/in/sanjayrsharma/  Key Questions and Topics from this Episode: (00:00) Welcome to the IoT For All Podcast (00:53) Introduction to Sanjay Sharma and Roambee (02:35) Supply chain current landscape (04:32) How to improve supply chain visibility (06:35) Supply chain standardization (08:00) How easy is it to implement supply chain visibility? (10:17) Stakeholder collaboration in supply chain visibility (13:47) AI in the supply chain (16:57) How to be successful with supply chain visibility (19:29) Learn more and follow up  SUBSCRIBE TO THE CHANNEL: https://bit.ly/2NlcEwm​ Join Our Newsletter: https://www.iotforall.com/iot-newsletter Follow Us on Twitter: https://twitter.com/iotforall Check out the IoT For All Media Network: https://www.iotforall.com/podcast-overview

Flower Drum Song was a benchmark in the the Golden Age of Hollywood grandeur and musical beauty -- and it was very racist by 2023 standards. We unpacked this Ro with stand-up comedian, actress, activist, and blazer of all trails Margaret Cho (Fire Island, Good Trouble, Hacks, Flight Attendant). Cho and Dino-Ray Ramos talk at length about the Rodgers and Hammerstein movie 1961 musical based on the 1958 Broadway musical on -- which was based on 1957 novel of the same name by the Chinese American author Chin Yang Lee. The Oscar-nominated film gave us memorable performances including "I Enjoy Being A Girl" by the legend Nancy Kwan -- but also a lot of blatant, heavy handed, gong-banging Orientalism. The Asian representation in this film is remarkable and a watershed moment for the Asian American diaspora in 1961 Hollywood as it was a majority Asian cast... it also has a scene where an Asian woman's teeth is inspected to make sure she would make a good wife. Cho admits that this is one of her favorite movies but also realizes its many problems. In this episode, we examine the Flower Drum Song and how it may be one of the most critical moments in cinematic history with problems that the Asian American diaspora are still facing in the 21st century. === Problematic Fave is presented by DIASPORA and is created, hosted and produced by Dino-Ray Ramos. The series is also produced by Sanjay Sharma of Marginal MediaWorks and edited by Brian Aguilar. Margaret Cho: margaretcho.com @margaret_cho on Instagram @themargaretcho on TikTok @margaretcho on Twitter DIASPORA: thediasporatimes.com; @realdiaspora on Twitter, Instagram Dino-Ray Ramos: @dinoray on Twitter and Instagram Marginal MediaWorks: @mrgnlmedia on Instagram Send your "problematic faves" to thisisdiaspora@gmail.com and we'll share them on the pod with our guests! --- Support this podcast: https://podcasters.spotify.com/pod/show/problematicfavepod/support

It's Pride! And what better way to dive into it than revisiting culturally relevant, trailblazing -- and traumatic -- movies about the LGBTQ+ community. This week we welcome artist, urban planner, activist, and host of the Fruta Fresca podcast, Jose Richard Aviles to talk about the film Boys Don't Cry directed by Kimberly Peirce and starring Hilary Swank, who won an Oscar for her portrayal of the real-life trans man Brandon Teena and his murder in Nebraska in 1993. They had lots to say about this very poignant -- but very problematic film for 2023. Released in 1999, Boys Don't Cry was a watershed moment for queer representation -- but we know that it hasn't aged well. Aviles and Dino-Ray Ramos navigate through this film with critical thinking, but most of all, with empathy. It's a tragic story and to see that translated on screen brings about a lot of risks in representation and makes space for toxicity and violence. Watching Boys Don't Cry in 2023 is like walking through a landmine of harmful and hard to watch portrayal of trans people as well as much-needed queer representation we have never seen in 1999. DISCLAIMER: Some topics we discuss may be triggering and difficult to hear. === Problematic Fave is presented by DIASPORA and is created, hosted and produced by Dino-Ray Ramos. The series is also produced by Sanjay Sharma of Marginal MediaWorks and edited by Brian Aguilar. Jose Richard Aviles: @soynalgona Fruta Fresca Podcast: @frutafresca.podcast DIASPORA: thediasporatimes.com; @realdiaspora on Twitter and Instagram Dino-Ray Ramos: @dinoray on Twitter and Instagram Marginal MediaWorks: @mrgnlmedia on Instagram Send your "problematic faves" to thisisdiaspora@gmail.com and we'll share them on the pod with our guests! --- Support this podcast: https://podcasters.spotify.com/pod/show/problematicfavepod/support

To kick off Pride Month we have a treat for you: a BONUS LIVE EPISODE of Problematic Fave! In this special episode, we travel to SeriesFest in Denver, Colorado where Problematic Fave host Dino-Ray Ramos moderated a special RuPaul's Drag Race conversation with local Denver drag queens Geo Conjure, Sexy Sadie, and Electra Dupri as well as Keith Garcia, artistic director of the Sie FilmCenter at Denver Film -- who is also a "drag mentor" of sorts, having worked with Drag Race winners Yvie Oddly (season 11) and Willow Pill (season 14). We don't follow the usual format of Problematic Fave. Instead, after the queens performed (it was an incredible a show!), we watched a preview of RuPaul's Drag Race All-Stars season 8. We then chatted about the impact of Drag Race on the queens' lives and we addressed the current landscape of anti-drag, anti-trans, and anti-queer legislation that is spreading across the country. They also told us a little bit about the amazing drag talent in the Denver and what makes the local scene so sickening. === Problematic Fave is presented by DIASPORA and is created, hosted and produced by Dino-Ray Ramos. The series is also produced by Sanjay Sharma of Marginal MediaWorks and edited by Brian Aguilar. SeriesFest: @seriesfest Keith Garcia: @constantwatcher Geo Conjure: @geoconjure Sexy Sadie: @sexysadie_69 Electra Dupri: @theelectradupri DIASPORA: thediasporatimes.com; @realdiaspora on Twitter and Instagram Dino-Ray Ramos: @dinoray on Twitter and Instagram Marginal MediaWorks: @mrgnlmedia on Instagram Send your "problematic faves" to thisisdiaspora@gmail.com and we'll share them on the pod with our guests! --- Support this podcast: https://podcasters.spotify.com/pod/show/problematicfavepod/support

Welcome back to another compelling episode of the Digital Supply Chain podcast! I'm your host, Tom Raftery, and this time around we're going deep into the world of real-time data, AI, and machine learning in the supply chain with Sanjay Sharma, the CEO of Roambee.In this exciting episode, Sanjay and I explore the workings of Roambee, a company revolutionising supply chain management by utilizing real-time data, AI, and machine learning. This means keeping an eye on your goods in transit has never been easier or more precise - just one of the ways Roambee is moving us towards autonomous supply chains.Sanjay shares some truly intriguing real-world examples showing how AI and machine learning are creating supply chains that can adjust and react dynamically. We're talking about a future where supply chains self-adjust in response to hiccups and disruptions, even those as unexpected as a ship stuck in the Suez Canal.If you're a business owner or involved in the supply chain management, you might be wondering where to start. Good news! Sanjay provides great insights on starting the journey towards a digitized supply chain, focusing on incremental improvements rather than being overwhelmed by the bigger picture. His advice is practical, applicable, and will put you on the path towards an efficient, technology-driven supply chain.So, come join us as we dive into the future of supply chains in this dynamic episode with Sanjay Sharma. You'll discover the fascinating world of technology-driven supply chains and maybe even get a few ideas to implement in your own business.I'm left wondering if I will need to re-brand this podcast to the Autonomous Supply Chain podcast!Enjoy the listen and don't forget to check out the video version of this podcast at https://youtu.be/BjcNB9tIcmISupport the showPodcast supportersI'd like to sincerely thank this podcast's generous supporters: Lorcan Sheehan Krishna Kumar Christophe Kottelat Olivier Brusle Robert Conway Alexandra Katopodis Alicia Farag Joël VANDI And remember you too can Support the Podcast - it is really easy and hugely important as it will enable me to continue to create more excellent Digital Supply Chain episodes like this one.CSCMP European Conference Registration pagePodcast Sponsorship Opportunities:If you/your organisation is interested in sponsoring this podcast - I have several options available. Let's talk!FinallyIf you have any comments/suggestions or questions for the podcast - feel free to just send me a direct message on Twitter/LinkedIn. If you liked this show, please don't forget to rate and/or review it. It makes a big difference to help new people discover it. Thanks for listening.

Happy Asian Pacific American Heritage Month! What better way to celebrate than with the spectacular ladies from the Add To Cart podcast, journalist and MTV News pioneer SuChin Pak and writer and actress Kulap Vilaysack who was but a young ingenue when she was featured in the "A Benihana Christmas" episode of The Office -- which we dive DEEP into for this ep of Problematic Fave. Vilaysack talks about her experience being involved this very divisive episode which stepped back into the spotlight when her co-star in the ep Kat Ahn talked about it. There is a lot to this episode so get yourself ready for three aunties talking shop about a problematic episode that includes very bad Asian representation of a beloved TV series during Asian Pacific American Heritage Month! === Problematic Fave is presented by DIASPORA and is created, hosted and produced by Dino-Ray Ramos. The series is also produced by Sanjay Sharma of Marginal MediaWorks and edited by Brian Aguilar. SuChin Pak: @suchinpak Kulap Vilaysack: @iamkulap Add To Cart: @addtocartpod DIASPORA: thediasporatimes.com; @realdiaspora on Twitter and Instagram Dino-Ray Ramos: @dinoray on Twitter and Instagram Marginal MediaWorks: @mrgnlmedia on Instagram Send your "problematic faves" to thisisdiaspora@gmail.com and we'll share them on the pod with our guests! --- Support this podcast: https://podcasters.spotify.com/pod/show/problematicfavepod/support

To many, Revenge of the Nerds is an innocent cult classic underdog story from 1984 -- but it is kind of trash. Actually it's a lot of trash and we unpacked a lot of that garbage with film critic and podcast co-host of Unspooled Amy Nicholson! It's amazing how this movie contained sooooo many problematic moments including a specific moment that is wildly offensive and would totally not fly today. We talk to Nicholson about THAT scene and how this movie constantly makes bad choices. We dive deep into this one so get your pocket protectors ready because it's going to be one problematic ride! === Problematic Fave is presented by DIASPORA and is created, hosted and produced by Dino-Ray Ramos. The series is also produced by Sanjay Sharma of Marginal MediaWorks and edited by Brian Aguilar. Amy Nicholson: Unspooled, @theamynicholson on Instagram DIASPORA: thediasporatimes.com; @realdiaspora on Twitter and Instagram Dino-Ray Ramos: @dinoray on Twitter and Instagram Marginal MediaWorks: @mrgnlmedia on Instagram --- Support this podcast: https://podcasters.spotify.com/pod/show/problematicfavepod/support

I said BRRRR! It's cold in here! There must be a Problematic Fave in the atmosphere! We kick off season 2 of Problematic Fave with a live episode that was recorded at SXSW in March. We were more than happy to welcome actor Jojo T. Gibbs who chose to talk about the iconic cheerleading cinematic and very problematic masterpiece known as Bring It On! You may recognize her from the series Twenties as well as the cannibalistic thriller Fresh. She also stars alongside Megan Stalter in the Hannah Pearl Utt-directed rom-com Cora Bora which made its premiere at SXSW. From the queer representation to the "urban" appropriation of it all, Gibbs and Dino-Ray Ramos dissect the classic film that Roger Ebert considered the Citizen Kane of cheerleading movies! === Problematic Fave is presented by DIASPORA and is created, hosted and produced by Dino-Ray Ramos. The series is also produced by Sanjay Sharma of Marginal MediaWorks and edited by Brian Aguilar. DIASPORA: thediasporatimes.com; @realdiaspora on Twitter and Instagram Dino-Ray Ramos: @dinoray on Twitter and Instagram Marginal MediaWorks: @mrgnlmedia on Instagram --- Support this podcast: https://podcasters.spotify.com/pod/show/problematicfavepod/support

What does representation on television and streaming REALLY mean? VP of Global Communications at Nielsen, Patricia Ratulangi, and CEO and Founder of Marginal Mediaworks, Sanjay Sharma, join TDS to discuss statistics found on Nielsen's recent study of television around women and AAPI representation, whether there's been progress made, how and why AAPI players may be overlooked, and so much more.Follow TDS on Instagram, Facebook, LinkedIn, and Twitter, and catch up with the hosts, Annika and Nehal, on their personals. Until next time, keep lighting that Desi spark!

10 March 2023. Jumeirah hotel has announced mobile check-ins for customers so we've been discussing whether it is better to have an online check-in or in person at the desk. We hear from Sanjay Sharma of the Jumeirah Group while Brandy and Tom pick different sides. Plus,  we speak to the group CEO of Dubai's first IPO of 2023 - Rashed Al Ansari. And, we talk aviation recovery with Kashif Khalid of IATA.See omnystudio.com/listener for privacy information.

Sanjay Sharma MD (Harvard University), MSc, FRCS, MBA is a retinal specialist who is a professor of ophthalmology at Queen's University.He is an internationally renowned eye surgeon, and has treated over 250,000 patients. Dr. Sharma is a clinician-scientist who has published over 300 scientific papers which have been cited over 10,000 time. He's the author of 3 textbooks, and I'm now proud to host him on Science 360!An innovator at heart, he has launched a series of digital platforms, including MEDSKL – a leading medical education platform that now reaches medical students from over 400 universities. And now he has introduced PREMEDSKL because high school students wanted something to help them prepare for their dream of becoming a doctor.This is a fascinating story of adaptation, innovation and creative thinking. Dr. Sharma and I have very similar philosophies of education, which is always fascinating, especially when we hold vastly different roles on opposite sides of the country. Except when you really stop to notice, although people are hailing from different backgrounds, at the heart, our differences diminish. And our aim to assist young people in finding success in their aspirations is one and the same.Tell your students about PREMEDSKL!! https://www.premedskl.comConnect with Dr. Sanjay Sharma on LinkedInhttps://ca.linkedin.com/in/sanjaysharmamd

Radio talk of Dr. Parshant Bakshi, Head Fruit Science, SKUAST-J with Sanjay Sharma of AIR, Kathua on 27-01-23 on Production of Strawberry in Jammu region in dogri to get good income by strawberry

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Sudden Cardiac Death (SCD) in sports In-flight emergencies Diagnostics Made Easy – Identifying Brugada syndrome on the ECG Host: Susanna Price Guests: Carlos Aguiar, Nicolle Kraenkel, Thomas Schmitt and Sanjay Sharma Want to watch that episode? Go to: https://esc365.escardio.org/event/837 Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Sanjay Sharma have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Thomas Schmitt has declared to have potential conflicts of interest to report: employed by Deutsche Lufthansa AG / Lufthansa Group Business Services. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

The financial reality of attending medical school can be particularly jarring for students from historically marginalized racial and ethnic groups who represent the first in their family to attend medical school. In this episode, first-generation medical students cover topics around financial literacy, debt management, different types of loans and repayment plans, building generational wealth, types of retirement plans, and more in an effort to financially empower medical students. Guests include: Sanjay Sharma, MD, MS, MBA; Michael Sweeney, MD, MBA, and Kabir Grewal, a medical student at the Florida State University and president of an organization at FSU that that educates med students about financial literacy and health care economics.

In this latest episode from the CPHI Podcast Series, Digital Editor Lucy Chard speaks to Sanjay Sharma, Global Head of Manufacturing, from Dr Reddy's. Sanjay has over 26 years of experience in roles encompassing sales, the supply chain, and technical operations.Pharma 4.0 is the upgrading of the pharma industry to a more digitalised state, including automation of processes and greater system integration. This has a wealth of advantages, such as leading to greater compliance and quality control in the manufacturing process. Pharma 4.0 also leads to increasing the sustainability of many aspects of the pharmaceutical chain. Dr Reddy's is a leading pharmaceutical company and is at the forefront of adopting industry 4.0 into their everyday systems. Dr Reddy's largest manufacturing facility in Bachupally, Hyderabad, India, recently joined the Global Lighthouse Network of the World Economic Forum, a network of over 100 manufacturing companies committed to developing and leading the progression into Industry 4.0 technologies. This commitment from Dr Reddy's will help to reduce manufacturing costs, production lead time, and energy consumption, as well as increasing the quality assurance throughout the manufacturing process.

A digital and automation tsunami is sweeping shop floors across global manufacturing hubs. VR, AR and AI are the new tools and workers. But is this digital evolution a true revolution or a FOMO trend? What is Zero-touch and lights-out manufacturing? Host Kiran Somvanshi and Kalpana Pathak give listeners an insider's deep dive into a new era of manufacturing at future-ready factories with Sanjay Sharma, Global Head of Manufacturing, Dr. Reddy's Laboratories and Sanjeev Sharma, CEO of ABB India.You can follow our host Kiran Somvanshi on his social media:Twitter - https://twitter.com/Kiran_ETLinkedin - https://www.linkedin.com/in/kiransomvanshi/You can follow our host kalpana Pathak  on his social media:Twitter - https://twitter.com/PathakKalpanaLinkedin - https://www.linkedin.com/in/kalpana-pathak-40395012/Catch the latest episode of ‘The Morning Brief' on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Google Podcasts.See omnystudio.com/listener for privacy information.

The global economy is dependent on complex and dynamic networks of supply chains powered by sophisticated logistics. This requires a significant amount of data to track shipments and operational characteristics of materials and goods. Roambee is a platform that collects, integrates, and analyzes all of that information to provide companies with the critical insights that businesses need to stay running, especially in a time of such constant change. In this episode Roambee CEO, Sanjay Sharma, shares the types of questions that companies are asking about their logistics, the technical work that they do to provide ways to answer those questions, and how they approach the challenge of data quality in its many forms.

Sanjay begins by introducing himself and his company along with use cases they are working on. He then discusses the role IoT plays on the supply chain and how new technology developments have furthered that. Sanjay then focuses on the food supply chain and the advances that have been made. The conversation then moves more high level with a discussion around compliance regulations, challenges in the industry, and advice for companies starting their IoT journey.Sanjay Sharma is a strategic thought leader with an impressive 17+ years of entrepreneurial experience building technology startups from the ground up. As CEO of Roambee, he is responsible for leading the company's vision, driving its worldwide business growth, and increasing its value. Sanjay has co-founded and led two successful Silicon Valley technology startups - KeyTone Technologies, which was acquired by Global Asset Tracking Ltd, and Plexus Technologies, which became an ICICI Ventures portfolio company. He has also been a part of the engineering teams at EMC, Schlumberger, and NASA. Sanjay has a bachelor's degree in Electronics Engineering from the University of Bombay and a Master of Science in Electrical Engineering from South Dakota State University.Roambee offers better supply chain visibility on demand for on-time, in-full, in-condition delivery of shipments and assets anywhere in the world. 300+ enterprises are improving customer experience, service levels, product quality, cash cycles, business efficiencies, sustainability, and automating logistics with Roambee's real-time insights & foresight. Over 50 are among the top 100 global companies in the Pharma, Food, Electronics, Chemicals, Automotive, Packaging & Containers, and Logistics sectors. Roambee's innovative AI-powered platform, and end-to-end monitoring solutions, deliver curated and highly accurate supply chain signals built on item-level, firsthand IoT sensor data and non-sensor inputs. The outcome is better multimodal ETAs, OTIF deliveries, 80%+ cold chain compliance and more, including 4X+ ROI on supply chain assets by optimizing utilization and inventory levels. 

B Side (Brooke): This week we head to India and then to Denmark to trace the steps of this serial killer, Sanjay Sharma aka Juan Carlos Sanchez Pinto Clasen. A Side (Adam): Part one of a three-part fantasy series, that you can finally watch after Adam talks about them. This week "Shadow and Bone." --- Support this podcast: https://anchor.fm/aside-bside/support

Doctors have been trained in pretty much the same way for many decades. Prior to any hands-on practical training, medical students spend about 2 years going through a series of lectures delivered by other doctors. In fact, this is the general model for how most professionals, and even undergraduate students, are trained – via in-person traditional sorts of lectures with a professor standing at the front of a large lecture hall, disseminating the information that is to be learned. But is this the best approach for learning, both in the context of medical school, and educational programs at large? Dr. Sanjay Sharma joins the podcast.

Sanjay Sharma of @sanjay1 is the head of Product at @pointme, where he leads the development of products that are helping thousands of people travel better with points. Sanjay himself has used points to travel to over 150 countries! In this episode, Sanjay and I discuss some of the main challenges people have when they search for good flight award availability, how to save points when you book flights, and some of the ways point.me makes all of this much much easier than it has been in the past. One of the great things about Point.me is that you can actually filter results by the type of points you have, whether it's Chase, Amex, Citi, Capital One, Bilt, or something else! Having a variety of cards that work with multiple transfer patterns is a key strategy for when you are leveling up your award travel game. Remember: when you're ready to apply for your next card that earns flexible points, whether it's a Chase Ink card, Capital One Venture X, Amex Gold or Platinum, or Citi Premier, don't use Google. Always ask your friends or favorite creators if they have a referral or affiliate link you can use. If you are interested in supporting this show when you apply for your next card, check out geobreezetravel.com/cards Download App in the Air at: https://links.appintheair.mobi/geobreezetravel Check out Point.me at: https://point.me/?pid=109 You can find Sanjay at: Instagram: https://www.instagram.com/sanjay1 Point.me Instagram: https://www.instagram.com/pointme You can find Julia at: Website: https://www.geobreezetravel.com Instagram: https://www.instagram.com/geobreezetravel Credit card links: https://www.geobreezetravel.com/cards Masterclasses: https://www.geobreezetravel.com/hangouts Patreon to access recordings of masterclasses: https://www.patreon.com/geobreezetravel Award travel coaching call: https://www.geobreezetravel.com/calendly Sign up for the newsletter and get exclusive access to sign up for free coaching calls: https://www.geobreezetravel.com/free-coaching Geobreeze Travel is part of an affiliate sales network and receives compensation for sending traffic to partner sites, such as milevalue .com. This compensation may impact how and where links appear on this site. This site does not include all financial companies or all available financial offers. Terms apply to American Express benefits and offers. Enrollment may be required for select American Express benefits and offers. Visit americanexpress .com to learn more.

In this episode of Seeing Clearly, Emaan Chaudry and Danielle Solish talk to Dr. Sanjay Sharma, a retinal specialist who is a professor of ophthalmology at Queen's University. Dr Sharma is an internationally renowned eye surgeon, and is a clinician-scientist who has published over 300 scientific papers which have been cited over 10,000 times and is the author of 3 textbooks, including the American Medical Associations, Evidence Based to Value Based Medicine. Dr Sharma is the recipient of millions of dollars in research funding, and has received numerous national and international awards for research, teaching and innovation in medicine, including those from the Canadian Institutes of Health Research (CIHR), Association of Faculties of Medicine in Canada (AFMC) and the American Academy of Ophthalmology (AAO). An innovator at heart, Dr. Sharma has launched a series of digital platforms, including MEDSKL - a leading medical education platform that now reaches medical students form over 400 Universities, and Optocase which upskills 22,000 eye doctors. Dr. Sharma, who holds advanced degrees in Epidemiology and Business Administration, completed his medical education at Harvard University. In this episode, we discuss: - What drew Dr Sharma to the field of ophthalmology. - Dr. Sharma's passion for technology and the digital platforms he has founded (MEDSKL and Optocase). - How Dr. Sharma balances his ophthalmic practice with his other interests. - Dr. Sharma's advice for learners. Check out Dr. Sharma's Websites Below: https://medskl.com/ https://optocase.com/ Check out our website: www.eyecurriculum.com Follow us on Instagram: www.instagram.com/EyeCurriculum Follow us on Twitter: www.twitter.com/EyeCurriculum

Roopak and Sanjay dissect Marginal's mission and the opportunity available to companies like BANG BANG and Marginal through the #DecentralizationOfHollywood; Blockchain and Web3 implications for entertainment and Sanjay's playbook for circumventing industry gatekeepers. See omnystudio.com/listener for privacy information.

Roopak talks to Sanjay Sharma about generative music NFTs, why lawyers-turned-producers have superpowers and Sanjay's circuitous journey through Hollywood including his experience working with Janet Reno on a task force investigating the President. See omnystudio.com/listener for privacy information.

In this episode Sanjay explains to us how to let the credit card companies work for you by maximizing your rewards potential with not only travel cards, but also when to open/close credit lines and how to hunt for offers. He has traveled the world on points and you can do it too if you stay tuned for all the latest hacks. From the Danakil Depression in Ethiopia, to a cheaper and wilder version of New Zealand in Central Asia and an overnight open air train across the Sahara desert sleeping on top of iron ore, Sanjay's stories satisfy not only the adrenaline junkies but also travelers looking for those off the beaten track destinations that don't make headlines. Be sure to also check out Sanjay's blog below for some fascinating articles about locales unknown. Fun fact:  There are currently in excess of 25 billion credit cards circulating worldwide. Card Pointers: consolidates credit card bonuses and gives you the latest deals and tips. Sanjay's BlogInstagram

BONUS-While our team is busy getting the next slate of VERY exciting episodes ready, here's one of our favorites from last year!  I don't remember laughing so hard in a interview...Zarna Garg is an Indian immigrant, mom, and lawyer turned New York comedian and TikTok star (https://www.tiktok.com/@zarnagarg) with more than 20 million views on the platform. She has performed standup at sold-out clubs across the country and headlined her own show My American Dream at the famous Carolines on Broadway. Unwilling to let the pandemic stop her, Zarna has kept audiences laughing with online comedy shows (which were recently profiled in the New York Times) and impromptu sets outside major landmarks across New York City including Central Park and The Met.Her debut romantic comedy screenplay “Rearranged” won the Best Comedy Screenplay Award at the 2019 Austin Film Festival (placing #1 out of 11,000 scripts), and was also a 2019 Academy Nicholl Fellowships Semi-Finalist. The script has been optioned by Marginal Mediaworks. 

Radio talk in Dogri with Sanjay Sharma of AIR, Kathua on 30-12-21 on Grading and Value addition are key to get good income by strawberry

The entrepreneurial mindset is often the driver of progress and success. Entrepreneurship is also what drives our guest, as Dr. Harbir Sian interviews Dr. Sanjay Sharma, a retinal specialist, professor of ophthalmology, and author of multiple books and research papers. As the Founder of OptoCase and MEDSKL, Dr. Sharma has helped provide education to tens of thousands of optometrists and medical students around the world. In this episode, we dive deep into what Dr. Sharma believes has brought him down this path of medicine and innovation. Tune in to hear their thoughts on entrepreneurship and personal fulfillment.Love the show? Subscribe, rate, review & share! http://www.aboutmyeyes.com/podcast/

Dr. Sanjay Sharma shares on Sustainability lessons from and for Family Enterprises Dr. Sanjay Sharma, Dean Grossman School of Business, University of Vermont USA Dr. Sharma is the Dean of the Grossman School of Business at the University of Vermont (UVM) since 2011. Before UVM, he was the Dean of the John Molson School of Business in Montreal Canada and the Canada Research Chair in Organizational Sustainability. He is a pioneer in corporate sustainability research with 9 books and over 100 articles in top tier academic journals. He received the Distinguished Scholar Lifetime Award from the Academy of Management in 2017. He serves on several Boards including Global Responsible Leadership Initiative (GRLI), Family Firm Institute (FFI), University of Sharjah College of Business, International Academy of Management, amongst others. Before pursuing an academic career, he was a senior manager and CEO with multinational corporations for 16 years.

Tusallatsiarnikuuiuk Carlos-ip kalaallit panigiit Danmarkiliaateriarlugit toqunnikuugai? Tamanna paasisaqarfiginerorusukkukku tusarnaarsinnaalerpat⛓ mail: inuartoq@gmail.com

It's a great honour to talk a man like sanjay sharma I am literally fan........

Have fun to interviewing sanjay sharma unke vicharo ne mera dil jeet liya such a great guy he is ......❣️❣️

Zarna Garg is an Indian immigrant, mom, and lawyer turned New York comedian and TikTok star (https://www.tiktok.com/@zarnagarg) with more than 20 million views on the platform. She has performed standup at sold-out clubs across the country and headlined her own show My American Dream at the famous Carolines on Broadway. Unwilling to let the pandemic stop her, Zarna has kept audiences laughing with online comedy shows (which were recently profiled in the New York Times) and impromptu sets outside major landmarks across New York City including Central Park and The Met.Her debut romantic comedy screenplay “Rearranged” won the Best Comedy Screenplay Award at the 2019 Austin Film Festival (placing #1 out of 11,000 scripts), and was also a 2019 Academy Nicholl Fellowships Semi-Finalist. The script has been optioned by Marginal Mediaworks. 

From immigrant kid, with a love of movies, to media entrepreneur, with a deep connection to the hip-hop community, Sanjay Sharma's professional journey has taken him across the American legal, tech and media landscapes. Carla welcomes him, on this first episode of a new season of Access & Opportunity focused on innovators working for equity in the media and entertainment industries. Now the Founder and CEO of Marginal Mediaworks, a media brand that’s all about genre storytelling from marginalized voices, Sharma’s perspectives are both familiar and radical. A serial entrepreneur, he has launched seminal ventures, including Machinima and ALL DEF Media, tuned in to underserved communities far from mainstream representation. In this episode, Sharma takes us through his eclectic journey from lawyer to screenwriter to CEO, and how he continues to advocate for the unheard stories in the margins. Come on and join us for the ride.

Speaker: Mr. Sanjay Sharma, consultant maxillofacial surgeon.The most-asked-about max-fax topics (mouth ulcers, neck lumps, clicky jaws, etc.) covered in one hour, plus your questions answered on any and all aspects of maxillofacial medicine and surgery. This is an interactive, down-to-earth, practically-applicable session aimed at primary healthcare professionals who just want some sensible advice and top tips. Do not expect research interests, long explanations of complex operations, or “why I am great”!”

Dr Sanjay Sharma is from Bangalore, INDIA, and he is the founder and medical director of FootSecure, a chain of podiatric clinics in India, enabling access to quality foot and ankle care for the 1.2 billion population. The India Today Group awarded FootSecure the Best Podiatry Clinic Chain. On this episode, we discuss the complicated road to becoming a podiatrist in India. Sanjay first completed his Masters in General Surgery and then pursued further studies in Podiatric Surgery in Arizona, USA. His interest was sparked after meeting Dr David Armstrong at a conference.   Dr Sharma is one of the few Podiatric Surgeons practising in India, and his main field of work is in Diabetic Foot Wound Management and Sports Injuries in the Foot. At present, he has also trained more than 500 doctors in Diabetic Foot Management. If you have any questions about this episode, please email me at tf@tysonfranklin.com, or you can connect directly with Dr Sanjay Sharma at sanjay@footsecure.com  Podiatry Business Coaching If you want to own and operate a Thriving Podiatry Business, there are four vital pieces to the business puzzle.   Marketing - You need a well thought out marketing strategy, not just more tactics.  Systems - You need systems that will support your marketing strategy and your team. Team - You need to develop a team culture that makes your work-life balance easier, not harder.  Diary - Your diary needs to be structured in a way that maximises patient numbers and increases daily profits.  You have two choices: There's the slow approach, where you learn by trial and error and do everything yourself, or you can fast-track your education and business success with one-on-one Business Coaching or join my next 12-Week Podiatry Business Reboot group coaching program.  If you want to know more, please email me at tf@tysonfranklin.com, and we can set up a Zoom Call and have a quick chat to see if I can be of assistance. 

Sanjay Sharma is the cofounder of Aye Finance which is a finance company that provides business loans to micro and small businesses. The company has raised $300 million from top tier investors such as CapitalG, FMO, Accion Venture Lab, and Aspada to name a few. 

Sanjay Sharma is the cofounder of Aye Finance which is a finance company that provides business loans to micro and small businesses. The company has raised $300 million from top tier investors such as CapitalG, FMO, Accion Venture Lab, and Aspada to name a few. 

Sanjay Sharma, a Nepali and Ph.D. candidate at the Department of Sociology, National University of Singapore, walks us through the construction of the Gurkha and the Gurkha soldiers migration. He discusses "Gender and Migration" as factors in the construction of the Gurkha that are part of his fascinating research focus. This research is a MUST HEAR!

One of the prime movers and shakers of Indian motorsport, Sanjay Sharma talks to Ed Sirish Chandran on

Have you known anyone who has suffered from cancer? In this episode of the Divine Career Design, Jodie has a special guest and Hematologist & Oncologist Sanjay Sharma. A Hematologist is a specialist in hematology, the science or study of blood, blood-forming organs and blood diseases. Sanjay specializes in providing medical care and treatment for those who are diagnosed with cancer. Many would not think becoming a Doctor is easy but if you are interested in any medical field as your career, this episode is a must. -- Welcome to the divine career design podcast. I'm your host Jodie Palmer! Weekly you'll hear me interview experts in their fields of study. We will look at the highlights and challenges within their careers. We will explore what an actual day to-day looks like in their practice and how to become an expert like them. I will answer your questions directly about the teen career exploration process and highlight special teen guests on the show to share their experience and unfolding through the career exploration process. Visit www.amplifyyou.org for more information.

Has the principle of shared decision making in athletes with known cardiac abnormalities placed our athletes, teams, and medical system at risk? Are there situations where accepted medical standards and risk management trump patient autonomy? What further steps can we take to generate the data needed to ensure that the athletes we clear in the future are safe to participate? On this episode of the AMSSM Sports Medcast host Devin McFadden, MD is joined by internationally recognized expert Sanjay Sharma, MD to discuss the risks and benefits encountered while making clearance decisions in athletes with known cardiac abnormalities. 

Has the principle of shared decision making in athletes with known cardiac abnormalities placed our athletes, teams, and medical system at risk? Are there situations where accepted medical standards and risk management trump patient autonomy? What further steps can we take to generate the data needed to ensure that the athletes we clear in the future are safe to participate? On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Devin McFadden, MD is joined by internationally recognized expert Dr. Sanjay Sharma, MD to discuss the risks and benefits encountered while making clearance decisions in athletes with known cardiac abnormalities.

The benefits and dangers of new media companies overseeing our viewing behavior, the evolution of advertising and America's status in global film and TV markets. SAG-AFTRA National Executive Director David White explores these topics with Jeffrey Cole, Director of the Center for the Digital Future at USC, and Sanjay Sharma, CEO of Marginal MediaWorks. **The views expressed by the guests are their own and not that of SAG-AFTRA. Any mention of products or services does not imply SAG-AFTRA’s endorsement.

The rise of companies such as Facebook, Netflix, and Amazon have turned the entertainment business upside down. With this incredible disruption comes exciting opportunities and concerning threats for performers. To help make sense of this all, SAG-AFTRA National Executive Director David White talks to experts Jeff Cole, a research professor and director of the Center for the Digital Future at USC, and Sanjay Sharma, co-founder and CEO of Marginal Mediaworks. **The views expressed by the guests are their own and not that of SAG-AFTRA. Any mention of products or services does not imply SAG-AFTRA’s endorsement.

→ Join us on Patreon ← Dr. Peter Attia, MD is the founder of Attia Medical, PC, a medical practice that focuses on increasing healthspan by minimizing the risk of chronic disease and preserving quality of life. Peter trained for five years at Johns Hopkins in general surgery and then spent two years at NIH as a surgical oncology fellow.  He has since been mentored by some of the most experienced and innovative physicians and scientists in the US and Canada. On this podcast Dr. Tommy Wood, MD talks with Peter about the critical components of lifespan and healthspan, including the factors he has identified as most important. They also discuss the controversial role of statin medication and take a close look at the necessity and sufficiency of risk factors for atherosclerosis. If you want to learn more about Peter’s work, he has a blog, a podcast and an active social media presence. Here’s the outline of this interview with Peter Attia: [00:00:35] Mellow Johnny’s Bike Shop. [00:04:01] Eddy Merckx. [00:04:16] Healthspan. Video: Peter Attia - Reverse engineered approach to human longevity. [00:05:23] Components of healthspan: cognitive, physical, emotional. [00:07:21] Lewis Hamilton; Ayrton Senna. [00:08:35] Reverse engineering healthspan. [00:11:34] Strength, power, aerobic and anaerobic fitness, flexibility. [00:14:57] Injuries affecting healthspan. [00:16:27] Exercise dosing studies: Marshall, Simon J., et al. "Translating physical activity recommendations into a pedometer-based step goal: 3000 steps in 30 minutes." American journal of preventive medicine 36.5 (2009): 410-415; Merghani, Ahmed, Aneil Malhotra, and Sanjay Sharma. "The U-shaped relationship between exercise and cardiac morbidity." Trends in cardiovascular medicine 26.3 (2016): 232-240. [00:17:26] Atrial fibrillation; mitochondrial injury. [00:18:39] Study: Nakayama, Hiroyuki, and Kinya Otsu. "Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases." Biochemical Journal 475.5 (2018): 839-852. [00:19:28] Functional threshold power (FTP). [00:23:58] Podcast: The High-Performance Athlete with Drs Tommy Wood and Andy Galpin. [00:23:59] Twin study: Bathgate, Katherine E., et al. "Muscle health and performance in monozygotic twins with 30 years of discordant exercise habits." European journal of applied physiology 118.10 (2018): 2097-2110. [00:24:50] The emotional component of healthspan. [00:24:56] The Drive Podcast: Paul Conti, M.D.: trauma, suicide, community, and self-compassion. [00:25:59] Dave Feldman; Podcast: How to Drop Your Cholesterol. [00:26:40] Sam Harris: Meditation. [00:29:30] Video: Commencement speech by David Foster Wallace from 2005 at Kenyon College, This is Water. [00:30:45] Vulnerability as a practitioner. [00:33:46] Time-restricted feeding. [00:34:23] Continuous glucose monitoring (CGM); Oura ring. [00:35:38] Factors contributing to longevity: deprivation of calories and rapamycin. [00:37:54] Benefits of fasting. [00:41:04] Free T3:Reverse T3 ratios during fasting. [00:42:50] Study: Finkelstein, Joel S., et al. "Gonadal steroids and body composition, strength, and sexual function in men." New England Journal of Medicine 369.11 (2013): 1011-1022. [00:43:30] Robert Lustig. [00:45:07] Multi-Ethnic Study of Atherosclerosis (MESA). [00:46:09] Statins; side effects. [00:48:36] Lipoprotein(a) - Lp(a). [00:49:19] Coronary Artery Calcium (CAC) scan. [00:54:03] The Drive podcasts: Dave Feldman, Ron Krauss, Tom Dayspring: (parts 1, 2, 3, 4, 5). [00:54:32] Risk factors for atherosclerosis: necessity and sufficiency. [00:56:16] Lead study: Lanphear, Bruce P., et al. "Low-level lead exposure and mortality in US adults: a population-based cohort study." The Lancet Public Health 3.4 (2018): e177-e184. [00:59:03] LDL cholesterol; ApoB. [01:01:15] Familial Hypercholesterolemia (FH). [01:04:41] Hyper-responders. [01:06:25] Saturated fat/cholesterol study: Jones, P. J., A. H. Lichtenstein, and E. J. Schaefer. "Interaction of dietary fat saturation and cholesterol level on cholesterol synthesis measured using deuterium incorporation." Journal of lipid research 35.6 (1994): 1093-1101. [01:09:43] Feldman Protocol. [01:11:48] The Drive podcast; peterattiamd.com.

Dr Carolyn Lam:                Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr Carolyn Lam, associate editor from the National Heart Center and Duke National University of Singapore. This week's journal features two papers that deal with genetic testing in young athletes and for sudden arrhythmic death, and with findings that may surprise you. They really show the complexities of this era of genetic testing and cardiovascular medicine, and in fact are discussed as growing pains in cardiovascular genetics. You must listen to our feature discussion, which is coming right up after these summaries.                                                 The first original paper this week suggests that targeting fibronectin polymerization may be a new therapeutic strategy for treating cardiac fibrosis. Fibronectin polymerization is necessary for collagen matrix deposition and is a key contributor to increased abundance of cardiac myofibroblast following cardiac injury. In today's paper, first author Dr Valiente-Alandi, corresponding author Dr Blaxall from University of Cincinnati College of Medicine and Heart Institute, and their colleagues hypothesized that interfering with fibronectin polymerization, or its genetic ablation and fibroblasts, would attenuate myocardial fibrosis and improve cardiac function following ischemia reperfusion injury. Using mouse and human cardiac myofibroblasts, authors found that the fibronectin polymerization inhibitor pUR4 attenuated the pathological phenotype exhibited by mouse and human myofibroblasts by decreasing fibronectin polymerization and collagen deposition into the extracellular matrix as well as by myofibroblast proliferation and migration.                                                 Inhibiting fibronectin matrix deposition by pUR4 treatment or by deleting fibronectin gene expression in cardiac fibroblasts confirmed cardioprotection against ischemia reperfusion-induced injury by attenuating at first left ventricular remodeling and cardiac fibrosis, thus preserving cardiac function. In summary, interfering with fibronectin polymerization may be a new therapeutic strategy for treating cardiac fibrosis and heart failure.                                                 The Insulin Resistance Intervention after Stroke, or IRIS trial, demonstrated that pioglitazone reduced the risk of both cardiovascular events and diabetes in insulin-resistant patients. However, concern remains that pioglitazone may increase the risk of heart failure in susceptible individuals. To address this, Dr Young from Yale Cardiovascular Research Center and the IRIS investigators performed a secondary analysis of the IRIS trial. They found that older age, atrial fibrillation, hypertension, obesity, edema, high CRP, and smoking were risk factors for heart failure.                                                 Pioglitazone did not increase the risk of incident heart failure, and the effect of pioglitazone did not differ across levels of baseline risk. It should however be noted that in the IRIS trial, the study drug dose could be reduced for symptoms of edema or excessive weight gain, which occurred more often in the pioglitazone arm. Overall, pioglitazone reduced the composite outcome of stroke, MI, or hospitalized heart failure in the IRIS trial.                                                 The next study highlights the importance of genetic variation in cardiac fibrosis and suggests that while fibroblast activation is a response that parallels the extent of scar formation, proliferation may not necessarily correlate with levels of fibrosis. In this paper from co-first authors Dr Park and Ranjbarvaziri, corresponding author Dr Ardehali, from David Geffen School of Medicine, University of California, Los Angeles, the authors utilized a novel multiple-strain approach known as the Hybrid Mouse Diversity Panel to characterize the contributions of cardiac fibroblasts to the formation of isoproterenol-induced cardiac fibrosis in three strains of mice.                                                 They found that isolated cardiac fibroblasts treated with isoproterenol exhibited strain-specific increases in the levels of activation, but showed comparable levels of proliferation. Similar results were found in vivo with fibroblast activation but not proliferation correlating with the differential levels of cardiac fibrosis after isoproterenol treatment. RNA sequencing revealed that cardiac fibroblasts from each strain exhibited unique gene expression changes in response to isoproterenol.                                                 The authors further identified LTBP2 as a commonly upregulated gene after isoproterenol treatment. Expression of LTBP2 was elevated and specifically localized in the fibrotic regions of the myocardium after injury in mice and in human heart failure, suggesting that it may be a potential therapeutic target. That brings us to the end of our summaries. Now for our feature discussion.                                                 We all know that t-wave inversion is common in patients with cardiomyopathy, however up to a quarter of athletes of African descent, and five percent of white athletes also have t-wave inversion on ECG, but with unclear clinical significance despite comprehensive clinical evaluation. Now, what is the role in diagnostic use of genetic testing beyond clinical evaluation when we investigate these athletes with t-wave inversion? Well we're about to get some answers in today's feature paper, and I'm so pleased to have the corresponding author of the paper, Dr Sanjay Sharma from St. George's University of London, as well as our associate editor Dr Mark Link from UT Southwestern.                                                 Sanjay, please let us know what you did and what you found. Dr Sanjay Sharma:            Well as you rightly say, that up to 25% of black athletes have t-wave inversion, as do three to five percent of white athletes. And these t-wave inversions often overlap with the sort of patterns that you see in patients with hypertrophic cardiomyopathy and arrhythmogenic cardiomyopathy. For example, 80% of people with hypertrophic cardiomyopathy have t-wave inversion as do 60% of patients with ARVC. Now we know that some ECG patterns, t-wave inversions in V1 to V4 are benign in black patients, but the significance of other ECG patterns is unknown. Cascade screening in family members with cardiomyopathy have shown that t-wave inversion may be the only manifestation of gene inheritance, and there are reports to suggest that some athletes with t-wave inversion do go on to develop overt cardiomyopathy. Now when we investigate the vast majority of our patients with t-wave inversion, these are our athlete patients, we don't actually find anything. But over the past decade, also, these has been major advance in next generation sequencing that allows us to perform genetic testing in a large number of genes that can cause diseases, capable of causing sudden death.                                                 And so, we thought we'd investigate the role of this gene testing in athletes with t-wave inversion. We looked at a hundred, 50 black athletes and 50 white athletes who had t-wave inversion, and we investigated them comprehensively with clinical tests. But we also added in a gene panel looking at 311 genes implicated in six cardiac diseases, notably hypertrophic cardiac myopathy, arrhythmogenic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction, long QT syndrome, and the brugada syndrome. We found that 21% of our athletes were then diagnosed with a cardiac disorder capable of causing sudden death, and the vast majority of these people had hypertrophic cardiomyopathy. And this diagnosis was based on clinical evaluation. When we looked at gene testing, we found that gene testing only picked up a problem in 10%. So, the diagnostic yield of gene testing was half that of comprehensive clinical investigation.                                                 When we actually looked at athletes who had nothing wrong with them in clinical investigation, and actually had a gene mutation, we found that only 2.5% of athletes who had t-wave inversion but clinically normal tests, actually had something wrong with them. And our conclusions were that gene testing picks up only half the athletes that clinical testing does, and gene testing is only responsible for identifying 2.5% of athletes with t-wave inversion, where clinical tests are negative. That was the summary of our study in short. We did find that black athletes were less likely to have a positive diagnosis of cardiac myopathy than white athletes, and black athletes are also less likely to have a genetic mutation capable of causing a cardiomyopathy than white athletes. Dr Carolyn Lam:                First and foremost, congratulations on such a beautiful paper, and so wonderfully summarized as well. It really seems to fly in the face, doesn't it? Of the way we've been discussing personalized medicine and saying that we're going to start whole genome sequencing everyone and that's going to provide all the answers for future disease risks. I mean, if I'm not wrong, what your paper is trying to tell us is that at this moment we don't have good examples where genetic testing may trump clinical diagnoses, and in fact we should be still focusing on a comprehensive clinical evaluation of patients and in the absence of a genotype we should learn to question what we're doing in genetic testing. Do you agree with that? Dr Sanjay Sharma:            You couldn't have said that more precisely. As I've said, the diagnostic yield of clinical testing was 21% versus only 10% with genetic testing. The diagnostic yield of pure genetic testing in people with otherwise completely normal findings clinically was only 2.5%. And the other thing that I forgot to tell you was that genetic testing, if we included genetic testing in addition to comprehensive assessment, cost us three times as much as clinical investigation on its own, and had we relied solely on genetics, and nothing else, it would have cost us ten times more than clinical testing. So our cost per making a diagnosis using genetics only would have amounted to $30,000 per condition. Dr Carolyn Lam:                Wow, what a great wake up call. Mark, you've thought a lot about this and in fact there was another paper in this week’s journal that has very complimentary messages. In fact you invited an editorial by Dan Roden, and I really loved his title of it, "Growing Pains in Cardiovascular Genetics." Would you maybe add your thoughts in relation to the other paper, as well as overall? Dr Mark Link:                     Sure. Circulation was very interested in these papers. These are really  ... Now, as Dan Roden says, "Growing pains." Twenty years ago when genetics came out it was looked upon as it was going to completely change our clinical medicine and precision medicine is really relying a lot on genetics. And while ultimately that may be the case, we are in a stage now where the honeymoon is over. And the other paper that was in this same issue was a paper by Hosseini  and colleagues, and it was the Clin Gen paper looking at the Brugada Syndrome abnormalities. Now the Clin Gen is an NIH sponsored group that takes individuals from a number of different institutions and actually gene testing, and tries to provide an independent assessment of the abnormality of genes. Previously is was companies that did this. A company would gene test ... They would look for gene abnormalities, try to link it with clinical disease, and they could basically then do just on their patients. But Clin Gen now is trying to tie all those companies together to get a broad consortion and to look at genetic abnormalities and whether they're truly pathologic, where there's areas of unknown significance, or whether they're truly not pathologic.                                                 So as an example, they took Brugada Syndrome, and they took the different gene abnormalities that have been described from basically different companies and different labs and different institutions, and they looked at the evidence behind the fact that they were truly pathologic, 'cause all 21 genes were defined as pathologic. They found in their independent assessment that only one ended up to be truly pathologic, and the others ones were disputed. And sort of another wakeup call that just because a single company calls a gene pathologic or Brugada Syndrome, does not make it pathologic necessarily. So we all thought these were two very important papers that looked at some of the limitations of genetic testing. We asked Dan Roden, who is really a very accomplished scholar in this field, to provide perspective on this. And I agree, I loved his title, "Growing Pains in Cardiovascular Genetics." And what he did is reviewed the history of genetic testing, and he actually starts before genetic testing and starts with Mendelian genetics, and [inaudible] genetics. And then 23 years ago they started linking that Mendelian genetics to gene abnormalities, especially in diseases such as long QT syndrome and hypertrophic cardiomyopathy.                                                 We've come a tremendous way in diagnosing gene abnormalities and associating them with these underlying cardiac myopathies and hind channel abnormalities. So no one doubts we've come a tremendous way, but there's a long way to go in terms of getting better diagnostic accuracy and really defining where these genetic testing are ultimately going to play out in clinical medicine. So everyone's excited about it, but I think these two papers are two cautionary tales that we do have to remember that genetic testing in 2018 is not the end all and be all. Dr Carolyn Lam:                I love that, cautionary tales. So important. But where do we go from here? What's the take home message for clinicians listening to this today in 2018? I mean is it that perhaps when we do these things we now need to include medical geneticists and genetic counselors as vital partners as we look at this all? Perhaps we need to not forget the primacy of clinical evaluation. What do you think, Sanjay? Dr Sanjay Shar:                  Well, there are guidelines from the American Medical Genetics side as to what one defines as a disease-causing mutation. But I agree that we need to be using certified laboratories that can actually interpret the genetic mutations. For example, in our study of athletes, 63% actually had variance of undetermined significance. So they had spinning mistakes in their genes which probably didn't account to anything at all, but had these mutations, or these so called variance of undetermined mutations been interpreted by someone who didn't really know much about this, these could have resulted in false positive results which could cause absolute chaos for an athletes career. So I do think this type of testing has to be governed very, very carefully and needs to be performed in very specialized and certified laboratories. Dr Carolyn Lam:                Indeed. Not just to the athlete, but to their families too, isn't it? Mark, what do you think is the take home message [inaudible 00:16:18]? Dr Mark Link:                     I think one of the big take home messages that I took away from these papers is that clinical medicine is not dead. In fact, clinical medicine in this day and age is still the prime way of taking care of patients. Genetic testing is still in its infancy. It doesn't help clinically in too many situations yet. It will in the future. It helps in the diagnosis, it's not as useful in the treatment. So we have a long ways to go with genetics. I like your comment that going forward we're going to need more genetic counselors to make sense of these results. Clinicians are going to have a hard time making sense of these results. I do think that there is plenty of role once a disease causing mutation has been defined, and in that situation it's invaluable in cascade screening in identifying other family members who may be affected, but outside that I do believe and I agree completely with both of you, that clinical medicine is not dead. And clinical evaluation should be number one and should enjoy it's prime time because that's where we still are at. And genetics is still in its infancy and so is cardiology. Dr Carolyn Lam:                Perhaps in selective settings ... We're not talking here about, for example, hypercholesteremia variance, we're not talking about cancer gene variance for which screening may be a little bit more advanced, and we may understand the gene phenotype associations that are perhaps- Dr Mark Link:                     I think that understanding gene phenotype associations are going to be critically important in the future. I think, as Sanjay said, the real use of genetic screening now is cascade screening for the family, and there it's invaluable. That you can tell if you've got a co-band with the disease, and with a defined pathological mutation. You can test siblings, sons and daughters, parents to see if any of them have the gene. I think that's where it should be used for sure in 2018. Dr Carolyn Lam:                Thank you so much Mark and Sanjay. So some precautions, some hope. Very, very balanced discussion. So much more we could discuss, so I really want to highly encourage our audience. Pick up this issue. You have to read these amazing papers and the editorials. Dr Carolyn Lam:                So, here's a podcast with all your colleagues, and don't forget to tune in next week.  

Performance isn’t as much as a priority as longevity is now, but I still love to compete.  This dilemma, so well stated by one of our clients, got us thinking.  It’s well documented that exercise extends both lifespan and healthspan, and the people we work with typically have no trouble meeting the widely recommended 150 minutes per week of moderate physical activity.  But what happens when you’re a competitive athlete training significantly more than that? For this podcast, I met up with Dr. Tommy Wood, MD, PhD and Performance Psychologist Simon Marshall, PhD to talk about the benefits and risks of intense exercise with regard to longevity and healthspan.  The science points to a U-shaped curve with dangers at both ends of the spectrum - not enough activity and also too much - and we discuss the point at which an athlete’s long-term health might suffer. We also talk about the kinds of exercise that will keep you strong and resilient as you age. Here’s the outline of this discussion with Drs Tommy Wood and Simon Marshall: [00:00:37] Lesley Paterson 2018 ITU World Champion; Podcast: Off Road Triathlon World Champion Lesley Paterson on FMT and Solving Mental Conundrums, with Lesley Paterson. [00:03:08] Performance, longevity, healthspan. [00:05:21] Atrial fibrillation. [00:05:51] Braveheart Coaching. [00:08:01] Up to 6-7 hours/week of exercise, moderate to vigorous intensity, correlates with increased lifespan. [00:08:29] 100 steps per minute; Study: Marshall, Simon J., et al. "Translating physical activity recommendations into a pedometer-based step goal: 3000 steps in 30 minutes." American journal of preventive medicine 36.5 (2009): 410-415. [00:09:08] Intense exercise associated with cardiac diseases; Study: Merghani, Ahmed, Aneil Malhotra, and Sanjay Sharma. "The U-shaped relationship between exercise and cardiac morbidity." Trends in cardiovascular medicine 26.3 (2016): 232-240. [00:09:17] Above 25-30 miles/week, some increase in mortality; Study: Lee, Duck-chul, et al. "Leisure-time running reduces all-cause and cardiovascular mortality risk." Journal of the American College of Cardiology 64.5 (2014): 472-481. [00:09:37] Diminishing returns vs. harm. [00:10:32] 2/3 of people not getting enough exercise. [00:10:47] Risks with high levels of exercise. [00:11:37] Podcast: Arrhythmias in Endurance Athletes, with Peter Backx. [00:11:49] Higher coronary artery calcium (CAC)  in marathon runners; Study: Kröger, Knut, et al. "Carotid and peripheral atherosclerosis in male marathon runners." Medicine and science in sports and exercise 43.7 (2011): 1142-1147. [00:12:12] Elevated troponin in marathon completers; Study: Regwan, Steven, et al. "Marathon running as a cause of troponin elevation: a systematic review and meta‐analysis." Journal of interventional cardiology 23.5 (2010): 443-450. [00:13:08] Extreme exercise unveiling congenital vulnerabilities. [00:14:26] Required ECGs, cardiac stress test. [00:16:15] Half of marathoners as former smokers; Study: Möhlenkamp, Stefan, et al. "Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners." European heart journal 29.15 (2008): 1903-1910. [00:17:30] Gut permeability, endotoxemia. [00:18:18] Hunter gatherer populations.  Studies: 1. Raichlen, David A., et al. "Physical activity patterns and biomarkers of cardiovascular disease risk in hunter‐gatherers." American Journal of Human Biology 29.2 (2017): e22919; 2. Pontzer, Herman, et al. "Energy expenditure and activity among Hadza hunter‐gatherers." American Journal of Human Biology 27.5 (2015): 628-637. [00:19:49] Periods of rest. [00:21:48] Why do people "over"-exercise? [00:21:50] Personal goals, exercise dependency, training goals. [00:23:24] Liking the gear, competition. [00:24:41] Self-referenced challenge, especially for long events. [00:26:19] Managing performance anxiety. [00:27:10] Competitor vs participant mindset; Podcast: Why We Self-Sabotage (And What to Do Instead), with Dr. Simon Marshall. [00:32:01] Short term vs. prolonged exposure to extreme exercise. [00:37:15] Building good exercise habits. [00:40:24] Tommy's exercise regimen. [00:40:41] Zach Moore: NBT Head of Strength and Conditioning. [00:41:57] Standing, walking, playing with dogs. [00:45:25] Strength and power in endurance sports. [00:48:01] Wingate test. [00:49:27] Simon's exercise regimen. [00:52:17] Aim for aerobic fitness and strength in top 25% of peer group.  

Our first episode in English. This time we talk DevOps, our guest is Sanjay Sharma from Sigma who's a Tomorrow Pilot at Sigma in this area. Participators: Simon Forsberg, Alexandra Stockman and Sanjay Sharma. Music by Psych Nein, for more visit http://psych-nein.bandcamp.com

This podcast is about the future of learning - a conversation with Prof. Sanjay Sharma, Professor and Vice President for Open Learning at MIT. A quote which nicely sums up the discussion comes from...

We recently chatted with Sanjay Sharma, MD, MSc (Epid), MBA, professor of ophthalmology at Queen's University and founder of MEDSKL, about trends in medical education and how MEDSKL can be used to improve your educational experience. The post Interview with Sanjay Sharma, MD, MSc (Epid), MBA appeared first on in-Training.

Dr. Carolyn Lam:               Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr. Carolyn Lam, associate editor from the National Heart Center and Youth National University of Singapore. Coming right up, we will be discussing fascinating new data on the prevalence of subclinical coronary artery disease in masters endurance athletes but first, here's your summary of this week's journal. The first paper provides insight into ischemic cellular post conditioning. Now, we know that cardiosphere derived cell therapy has been utilized as a strategy to treat ischemic heart disease and reduce chronic scar burden when administered months after myocardial infarction. In the current study, by first author Dr. de Couto, corresponding authors Dr. Marban and Berman from Cedars-Sinai Heart Institute in Los Angeles, California, the authors used rat and pig models of myocardial infarction to show that exosomes, which are nanosize lipid bi-layer vesicles, actually mediate the cardio protective effects of cardiosphere derived cells when administered after reperfusion of myocardial infarction.                                                 They further show that treatment with either cardiosphere-derived cells or their secreted exosomes reduce infarct size and improved functional recovery. Using RNA sequencing to determine exosome content and alterations in gene expression profiles on macrophages from cardiac tissue or bone marrow, they found that a specific micro RNA species miR 181-B within the exosomes, acted on macrophages and was implicated as a key mediator of the cardio-protective benefits. Thus, this study gives new reason to test the idea that allogeneic cardiosphere-derived cells may be efficacious in preventing scar formation and improving cardiac function, when given in the earlier reperfusion period. The data further support that exosomal transfer of miR 181-B from these cardiospheric-derived cells into macrophages underlie the cardio-protective effects after reperfusion.                                                 The next study describes a potential new therapeutic strategy for vasoproliferative retinopathy which can underlie age-related macular degeneration, the leading cause of blindness in industrialized nations. First author, Dr. Bucher, corresponding authors Dr. Yea and Friedlander, from the Scripps Research Institute in La Jolla, California used rodent models of retinal neo-vascular disease to show that Tspan-12, beta-catenin signaling plays an important role in the development of vasoproliferative retinopathy. As background, Tspan-12 belongs to the Tetraspanin family, which mainly includes cell surface proteins characterized by four transmembrane domains and two extra cellular domains.                                                 Members of the Tspan family participate in a diverse cellular processes and act as signaling platforms by forming Tspan-enriched micro domains in plasma membranes. The authors went further to use a novel phage display combinatorial antibody library to specifically design a Tspan-12 blocking antibody which is capable of interacting with human and mouse Tspan-12 antigen. They then provided strong evidence that the Tspan-12 blocking antibody prevents developmental pathological neovascularization in  murine models of vasoproliferative retinopathy. Combination therapy with a known anti-VEGF agent demonstrated significant synergy supporting the potential clinical use of the anti-Tspan-12 antibody as a novel angiomodulatory agent.                                                 The next study addresses the paradox that blacks have higher coronary heart disease mortality compared with whites, but non-fatal coronary heart disease risks may be lower for black versus white men. To address this paradox, first author Dr. Colantonio, corresponding author, Dr. Safford and colleagues from Weill Cornell Medical College in New York, compared fatal and non-fatal coronary heart disease incidents and case fatality among blacks and whites in three studies. The Atherosclerosis Risk in Communities or ARIC study, cardiovascular health study, and reasons for geographic and racial differences in stroke or regards study, all stratified by gender.                                                 They found that the incidents of non-fatal coronary heart disease was consistently lower among black versus white men, although black men have a higher burden of unfavorable social determinants of health and cardiovascular risk factors and a higher fatal coronary heart disease incidents. Following adjustment for social determinants of health and cardiovascular risk factors, black men and women had a similar risk of fatal coronary heart disease, but a lower risk of non-fatal coronary heart disease compared with white men and women respectively. Finally, blacks with incident coronary heart disease had a higher case fatality compared with whites and the difference remained similar after adjustment for social determinants of health and risk factors. Thus, there is an apparent lower risk for non-fatal coronary heart disease among black versus white men and women, which needs to be further studied. Blacks have a higher risk of their initial coronary heart disease event being fatal compared with whites, highlighting the need for reinforcing primary prevention in this population.                                                 The next study provides important information on the burden of re-admissions after hospitalization for critical limb ischemia. First author, Dr. Kolte, corresponding Dr. Aronow and colleagues from Brown University in Providence, Rhode Island, used the 2013/2014 nationwide re-admissions databases to identify almost 61,0000 hospitalizations for primary diagnosis of critical limb ischemia during which patients underwent endovascular or surgical therapy. They found a 30-day re-admission rate of 20.4%. Independent predictors of 30-day re-admission included presentation with an ulcer or gangrene, age above 65 years, females, large hospital size teaching hospital status, known coronary artery disease, heart failure, chronic kidney disease, anemia, coagulopathy, obesity, major bleeding, acute myocardial infarction, vascular complications, and sepsis. Interestingly, mode of revascularization was not independently associated with re-admissions.                                                 The most common reasons for re-admissions included infections, persistent or recurrent manifestations of peripheral artery disease, cardiac conditions, procedural complications, and endocrine issues. Finally, the costs of 30-day re-admissions for critical limb ischemia during the study period were 624 million U.S. dollars. Thus, this study provide knowledge of independent predictors and reasons for re-admissions that will help clinicians and hospitals to identify, develop, and implement strategies to reduce re-hospitalizations and healthcare costs associated with critical limb ischemia. The final study tells us that there may be a direct relationship between life-long exercise volume, and coronary atherosclerosis in athletes. Dr. Aengevaeren and colleagues from Radboud University Medical Center in the Netherlands, studied 284 middle-aged men engaged in competitive or recreational leisure supports, using contrast enhanced CT to assess coronary artery calcification and plaque characteristics.                                                 Participants also reported life-long exercise history patterns and exercise volumes were quantified as metabolic equivalent of task or met minutes per week. They found that participants in the more than 2,000 met minutes per week group had a higher prevalence of coronary artery calcification and atherosclerotic plaques. The most active group did, however, have a more benign composition of plaques with fewer mixed plaques and more often, only calcified plaques. These observations may explain the increased longevity typical of endurance athletes, despite the presence of more coronary atherosclerotic plaques in the most active participants. Well, that wraps it up for your summaries. Now for our featured discussion.                                                 Our current physical activity guidelines recommend 150 minutes of moderate exercise and that's supposed to protect against cardiovascular disease and increase longevity. However, what do we really know about the dose response relationships and the effects of exercises doses that exceed current recommendations. Well, recent data, including a paper in this week's issue, suggests that long-term, high volume endurance exercise may actually accelerate, rather than reduce coronary atherosclerosis. To discuss this exciting paper, we have the corresponding author, Dr. Sanjay Sharma, from Saint George's University of London, as well as editor of digital strategies and associate editor at UT Southwestern who handled this paper, Dr. Amit Khera. Welcome, gentleman. Dr. Amit Khera:                 Good morning. Dr. Sanjay Sharma:          Thanks for having us. Dr. Carolyn Lam:               First, Sanjay, oh yikes! As a runner and as a person who strongly advocates regular exercise, please, please, put us out of our misery. Tell us what you've found and what you think are the possible explanations. Dr. Sanjay Sharma:          I'm a runner too, and I don't think anyone would argue that the benefits of exercise on the cardiovascular system are unrivaled. People who exercise regularly do reduce their risk of an adverse event from a heart attack by 50% when they're in their 5th and 6th decade and they live around three years longer than people who don't exercise at all. Now as you rightly point out, the current recommendation suggests 2 1/2 hours of moderate physical activity per week and by that I would mean, at maximum, a 15-minute mile pace. Clearly, our endurance athletes exercise much, much more than that. They exercise 10 to 20 times greater than that volume and in parallel with this has been the emergence of a large number of people participating in marathon runs. For example, in Europe, there were two million marathon runs per annum and that figure's going up by about 5%.                                                 Coinciding with this burgeoning increase in endurance exercise, is the development of several reports that show that exercise may cause release of biomarkers of cardiac damage. Animal experiments have shown that exercise may cause scaring in the heart and human studies have shown that some marathon runners have more calcium in their coronary arteries compared to relatively sedentary individuals. One of the problems with these studies is firstly, the biomarker release is very transient, it goes away after about two days. Animal experiments cannot really reflect what goes on in human beings because they're artificial and animals are forced to exercise with electrical shocks, et cetera. The studies in human beings have been conducted in runners who have been former smokers.                                                 In fact, the most commonly reported study or cited study, contained individuals of whom 50% had risk factors for coronary artery disease. What we decided to do was to do a clean study, where we took 150 individuals who had none of the risk factors for coronary artery disease and 92 relatively sedentary controls who exercise within the normal limits. We have to exclude a lot of people because we have to exclude anyone that had ever smoked, anyone that had high blood pressure, high cholesterol, or a family history of permanent cardiac disease. We actually subjected them to all sorts of investigations and we found that a small number of male runners had more calcium in their arteries compared to sedentary individuals. Dr. Carolyn Lam:               Wow! Please tell us that there's something good that you can say about that. First of all, I really want to congratulate you on this most elegant study and Amit, I'm sure you put in what the editor's thought but we're just so proud to be publishing such a high quality study here. Amit, is there anything you might want to add of what the editors thought? Dr. Amit Khera:                 Sure, I first want to congratulate Dr. Sharma and his colleagues. This was a carefully done study and we've talked a bit about the coronary calcium but there was extensive investigation and I really think this advanced the field. Sounds like all three of us are runners, so this hit home to all of us and as he mentioned, this has been a very hot area and one that's been very controversial. I think here what we have is a manuscript that really helped move the field forward, helped us better understand the biology. The one thing I'll comment on that we found very interesting was the observation that those that were the masters athletes actually had more of a calcific phenotype, where as those that were not looked like a soft plaque phenotype, if you will. Actually, if you look, we have a companion article in circulation looking at sort of dose dependent finding a similar finding. My question, now turned back to Dr. Sharma is, what do you counsel your patients now with these findings? Has it changed now how you recommend exercise or your thoughts on how you counsel them? Dr. Sanjay Sharma:          Well, we examined 152 different athletes, or masters athletes in 92 controls. These athletes were aged 56 years old, who'd been training for 36 years and had immediate marathon number of 13. Now, what we've found in these individuals is that a small number of males, that's 11%, had a coronary artery calcium score of more than 300. Some men had more plaques than sedentary individuals and these plaques were distributed throughout all three coronary arteries. When we looked at the pathology of the plaques very carefully, we found that the plaques in the athletes were calcified. Indeed, 72% of athletes had very calcified plaques. We know that such calcified plaques are stable, they're less likely to fissure and are less likely to cause coronary thrombosis and therefore, acute myocardial infarction.                                                 This led us to propose that although exercise may be causing some atherosclerosis through the sheering and stressful source during exercise of the bending and kicking of vessels, we believe that the repair mechanism here is different to that seen in people who smoke or who have high cholesterol or high blood pressure. The repair mechanism results in very calcified and stable plaques in athletes and this may actually mitigate the risk of acute myocardial infarction and may explain why the number of people who actually suffer an acute myocardial infarction during a marathon run is very small, around 1 in 50,000, and no different to the number of people who suffer a sudden cardiac arrest playing football or basketball, due to congenital or inherited abnormalities of the heart.  Dr. Carolyn Lam:               Sanjay, those are just such important points to keep in mind as we read your paper. It did strike me as a significant minority, actually, of these long term endurance athletes who develop significant coronary artery calcification and it could potentially be a clinically benign phenotype. At the end of the day, this is a cross-sectional study, isn't it? We can't, I suppose, extrapolate into the clinical events. What are your postulations there and what could be future work that you're planning? Dr. Sanjay Sharma:          Well, you make a good point. This is a cross-sectional study and the demonstration of an increased cardiopathy calcium does not necessarily reflect future cardiac events. We have followed these individuals up for the last 18 months. These masters athletes and have not demonstrated a single one to develop an acute event that would last 18 months. We really don't know what the meaning of these plaques is. I think the only thing to do now, being we've got the liberty of having so many people that do marathon runs and so many people who've been exercising for three or four decades, we can actually do a prolonged follow up study, so the answers will be a while coming. To follow these people up with high calcium, just to see whether they do go on to develop adverse events in the future. All our study has shown is that some male athletes who've exercised lifelong get an increasing number of plaques. These plaques appear to be calcified and stable and the long term effects of such  plaques is unknown. Dr. Carolyn Lam:               Sanjay, just circling back to Amit's question earlier and maybe Amit, you could take it to after this. What do we recommend to our athletes who come in and have a high coronary artery calcium score? Do we tell them to stop? Dr. Sanjay Sharma:          I certainly wouldn't and I'm much less worried about an increase coronary calcium score in a lifelong runner or cyclist than I was 10 years ago. It appears that these plaques are there in some individuals, they are calcified, they appear stable. Given the fact that we know that coronary events during marathon running in experienced runners are very, very low indeed. I don't think I would be keen to do anything about it, not even consider stacking therapy based on our findings at present. As I said before, we do need longitudinal follow up to really identify all ascertain the precise implications of these plaques in masters athletes. Dr. Carolyn Lam:               Right, and this is again recognizing that your particular population was free of traditional cardiovascular disease. Of course, if we were to find these risk factors in our athletes, we would most certainly treat the traditional risk factors. Amit, anything to add there? Dr. Amit Khera:                 I think that was an excellent point about his approach to counseling patients. I will mention on the editorial staff, we felt like this was such an interesting area with emerging data and fast moving, that it was warranting of an editorial. I recommend people to look at the one by Aaron Baggish and Ben Levine. I think they had a very similar conclusion and that was that they don't necessarily proscribe exercise in patients with high coronary calcium but rather, focus on risk mitigation strategy, focusing on risk factors as we normally would do. I think the conclusions are similar and the thoughts in that editorial were insightful, pairing both of these papers and helping us make sense out of this really evolving field. Dr. Carolyn Lam:               Well, thank you Sanjay and Amit for this wonderful discussion. I learned so much as I'm sure our listeners did. You've been listening to Circulation On The Run. Tune in next week. 

Medical education is not something you think of getting through an online course. There s so much detail, so much minutia – you expect that you d HAVE to sit in a classroom or do work in a lab to do it well. But Dr. Sanjay Sharma doesn t think that s necessarily true, especially in light of the methods of learning that work best for the millennial generation that s entering med school these days. On this episode, med school meets creativity as we unpack the truly innovative things Sanjay and his team are doing to educate new students with new technologies. It s all on this episode of Converge.     Open your eyes to what s going on around you. It could be how you identify the next big thing. When Sanjay Sharma noticed that the students in his medical lectures were not paying attention, he wasn t surprised. But when he noticed that what they were doing instead was watching Youtube videos or browsing the internet, he began to question things. A conversation with his wife led him to ask whether the modalities used in the med school classroom are as effective as they can be and if not, what can be done to change. On this episode, you’ll hear Dr. Sharma s journey from physician and med school educator to tech entrepreneur and online educator. His journey and in particular his ability to stop and observe what s happening around him are exactly what equipped him to take advantage of an opportunity and meet a tremendous need.   Medical education through animation and video is not so easy to produce. Some of the challenges Dr. Sharma s team faces when putting the important medical concepts they teach in digital form have to do with what Dane calls translation issues. Somebody who is creative and knows the technical side of the online educational platform has to be able to understand the medical concepts needing communication, well enough to translate them into simple, memorable phrases that can be communicated visually. It s not an easy leap to make but Sanjay s team has done an incredible job forging a merger between creativity and medical education – and it s catching on. Learn more on this episode. Advice for those seeking to do what s in them to do. Listening to this episode of Converge you ll hear two remarkable stories. One of Dr. Sanjay Sharma and how he has built a prestigious medical career AND has built a team to develop an online medical education curriculum. The other is of his son, a young man who is very much a prodigy when it comes to painting. It s easy to hear their stories and their backgrounds and make excuses for yourself. You re not a Doctor after all. You didn t grow up in a well-off home. But Dr. Sharma addresses that issue powerfully on this episode when he says that you ve got the power to decide that what you have to add to the world matters. And you have the power to make it happen as well. You can hear his solid advice by listening. Meet Dr. Sanjay Sharma, medical professor and entrepreneur Dr. Sanjay Sharma, MD, MSc, MBA is the founder of www.Medskl.com a new open-access platform developed to redesign medical education. Boasting over 170 award-winning medical faculty from across the world, medskl.com brings a modern approach to teaching medicine, featuring digestible whiteboard animations, short video lectures, and concise summaries designed to appeal to today s digital learners. Medskl.com s content is available for anyone in the world to access for free and students from over 60 Universities have joined medskl.com in the past 6 weeks since launch. Dr. Sharma is a professor of ophthalmology and epidemiology at Queen s University, has authored over 200 research articles and 3 books including the American Medical Association s Evidence-based to Value Based Medicine. His research in macular degeneration, health economics, and medical education has been cited in the scientific literature over 6,000 times. Dr. Sharma completed his medical education at Harvard University. Outline of this great episode [1:00] Dane s introduction to Dr. Sanjay Sharma, today s guest. [3:40] The body of work Sanjay has created over the years. [7:57] What is Medskl and what does Sanjay hope to accomplish with it? [18:29] The challenges of communicating scientific concepts creatively with animation. [26:46] The life lessons Sanjay applies from his and his son s stories. Resources & Links mentioned in this episode Robin Sharma Evan Sharma Khan Academy The Story of Stuff GUESTS RESOURCES Webiste: Medskl.com Dr. Sharma on Twitter: @sanjaysharmamd Google Scholar articles by Dr. Sharma Connect with the Converge team: Website: Fastermind.co Facebook: facebook.com/followdane/ LinkedIn: linkedin.com/in/danesanders Twitter: twitter.com/danesanders Audio Production and Show notes by PODCAST FAST TRACK The post S.2 Ep. 008 – Creativity Meets Medical Education with Dr. Sanjay Sharma appeared first on Fastermind.co.

Inside Health listener and keep fit enthusiast, David Heathcote, wanted advice on how far he should safely push himself when he's training in the gym. In this special programme about the health benefits of keeping active, Dr Mark Porter helps David to find the answer to his question about the exercise "sweet spot". If you struggle to screw the top off a jar, or use your arms to push yourself out of your chair, that's a sure fire sign, according to Dr Philip Conaghan, consultant rheumatologist and Professor of Musculoskeletal Medicine at the University of Leeds, that your muscles are weak. And the good news is that building muscle strength will protect your joints, not damage them. Dr Conaghan tells Mark that there's a worrying lack of understanding about the impact of muscle weakness on arthritic joints. Over the last decade there's been a growing interest in the relationship between activity and the risk of developing cancer. Studies have demonstrated that exercise appears to have a protective effect against at least four different cancers (breast cancer, colon cancer, endometrial cancer and some upper gastrointestinal cancers) and that being fit helps recovery from cancer too. Dr Denny Levett, a consultant in peri-operative medicine and critical care at University Hospital, Southampton who has a special interest in the relationship between exercise and health, says the reason for the apparent protective effect of fitness is still being researched but the evidence that the effect exists is now widely accepted. Professor of Clinical Cardiology, Sanjay Sharma from St George's University of London outlines the benefits to our hearts of keeping active and Park Run fan and regular Inside Health contributor, Dr Margaret McCartney, admits how running has become something of an obsession and promises that the evidence shows that when it comes to getting fitter, it's never too late to start.

From this week all UK babies will be vaccinated against that most feared disease, meningitis B, the first country in the world to take this step. But the decision to include Men B in the national immunisation programme has come too late for parents, Freya and Ross. A year ago their baby daughter, Harmonie, nearly died after contracting the infection. Her arms and legs as well as the tip of her nose had to be amputated because of the resulting sepsis. Sue Davie, Chief Executive of Meningitis Now tells Mark that the vaccine is great news and will save many lives. But she hopes in the future that it will be offered to older babies and young children, as well as another at risk group, adolescents. Mental health problems have long been linked to fluctuating hormone levels, at times of menstruation, childbirth and menopause. Dr Michael Craig who runs the Female Hormone Clinic at the Maudsley Hospital in London discusses the role of hormone replacement treatments. Statins are the most commonly prescribed medicines in the UK. They work to lower the level of cholesterol in your blood. There's been considerable debate about when doctors should start prescribing statins and NICE, the National Institute for Health and Care Excellence, had been keen for GPs to be paid to put more patients on the cholesterol-reducing drugs. Dr Margaret McCartney outlines the controversy and NICE Deputy Chief Executive, Professor Gillian Leng, tells Mark that the health advisory body has listened to concerns and why their new statins targets are now to be tested in the field. Young, healthy, sporty people don't get heart attacks. Except when they do. Dr Stuart Miller, Clinical Director of Sport and Exercise Medicine at the University of Bath admits that he was shocked when he had a heart attack, even though he cycles, swims and eats a healthy diet. Sanjay Sharma is professor of cardiology at St George's Hospital in London and he tells Mark how common unexpected heart attacks are. Producer: Fiona Hill.

Sport was the theme of 2012’s British Cardiovascular Society Conference, and Sanjay Sharma (professor at the CRY Inherited Cardiac Diseases and Sports Cardiology Unit, St Georges Hospital) spoke about sudden cardiac death in athletes.Christopher Burrell (consultant cardiologist at the Southwest Cardiothoracic Centre, Plymouth) caught him after the session to ask about the conditions which cause SCD, what to look out for on an athlete’s electrocardiogram or echocardiogram, and whether or not we should be screening.See also:Webcasts from all the sessions at the British Cardiovascular Society Conference 2012 http://bit.ly/ZMGmUE

Whooping cough is on the rise - but the official figures could be the tip of the iceberg, according to one doctor. Retired GP from Nottinghamshire Dr Doug Jenkinson has spent most of his professional life researching the condition which is also known as pertussis. He says that instead of around 1,700 cases every year, there could be tens of thousands. He personally has seen around 700 cases and a blood test available for the last few years has helped to confirm cases. The key to diagnosis is a cough which almost causes choking - sometimes with the characteristic whooping sound - which then subsides for a few hours. The cough can last up to 3 months. The cough can be dangerous for infants under the age of one - who can catch it from parents and grandparents. Dr Jenkinson suggests a vaccine booster could be offered to parents-to-be. Following the recent high profile cases of elite sportspeople collapsing with undiagnosed heart conditions should screening be made available to amateurs? Since the collapse of footballer Fabrice Muamba on the pitch earlier this year the profile of so-called silent heart conditions has risen. Sanjay Sharma is Professor of Cardiology at St George's Hospital - he works closely with the charity Cardiac Risk in the Young or CRY - and supports screening. CRY believes that screening will pick up an abnormality in as many as 1 in 300 youngsters - although it freely admits that the vast majority of these would never have gone on to develop a serious problem. And it is the resulting disruption to these children's lives that puts some people off screening, not least because they far outnumber those likely to be saved by the tests. Dr Anne Mackie is the Director of Programmes for the UK National Screening Committee. She says that she wouldn't even opt for screening for her own children Following last week's feature on unfounded rumours that toys were to be banned from GP waiting rooms to reduce the risk of cross infection, an Inside Health listener emailed the programme to ask about the evidence behind products marketed as killing germs on the various surfaces we touch at home. So what's the science behind adding antibacterial agents to household products? Dr Kamran Abbasi, Editor of the Journal of the Royal Society of Medicine reveals that there is no evidence to show that products labelled 'antibacterial' reduce the number of infections in the home any more than 'regular' cleaning products. GP Margaret McCartney explains why she thinks the latest campaign to encourage more self-care for minor ailments is wrong to imply that people who consult their doctor about dandruff are wasting NHS resources. The NHS 'Choose Well Summer' campaign says 'self care is the best option if you have a summer health complaint' and it's supported by the National Association for Patient Participation, who say it's all about 'empowering individuals'. The campaign was launched with headlines about the 40,000 visits in a year to GPs which were for dandruff. But what was really behind those consultations? And how good are we at looking after our own health? Computer games are being used to help people recover from strokes and brain injury, thanks to experts in Reading. Products like Microsoft's Xbox Kinect - which can recognise a player's movements - are being adapted by Professor Malcolm Sperrin at the Royal Berkshire Hospital. The technology allows patients to select an activity - from dancing to golf or ten pin bowling - and monitor their progress as part of their recovery. The charity Headway - which supports people with brain injury - is using the technology in the community to help people to recover at home.